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INTRODUCTION 
In recent years, considerable attention has been 
directed to a newly recognized group of disease syndromes 
occurring in cattle which have somewhat similar clinical 
and pathological manifestations. The first syndrome observed 
was given the name "virus diarrhea." Later, a more severe 
clinical manifestation of this syndrome was designated 
"mucosal disease." Today, the syndrome is usually referred 
to as the bovine viral 'diarrhea-mucosal disease complex. 
Even though the etiological agents involved in this complex 
are serologically related, it appears that the terms viral 
diarrhea and mucosal disease can best be used in describing 
the clinical manifestation of the disease complex as it 
occurs in the field. 
The disease syndrome probably has been present for a 
number of years and has not been recognized or undoubtedly 
mis-diagnosed in the field. The significance of this disease 
complex is not fully known, but undoubtedly it plays a major 
role in economic loss to the cattle industry. At the present 
time, the disease is known to have world-wide distribution . 
At the National Animal Disease Laboratory in 1962 , a 
clinical case of mucosal disease occurred in the experimental 
herd. A cytopathogenic virus was isolated from various 
tissues collected at necropsy, which was designated the 
NADL-MD strain of bovine viral diarrhea-mucosal disease virus. 
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The objectives of this study are to characterize the 
NADL-MD virus and to partially elucidate the disease 
syndrome in the involved herd by virological and 
serological procedures. 
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REVIEW OF LITERATURE 
In 1946, Olafson et al. (45) described the occurrence 
of a highly contagious disease of cattle in New York 
characterized by high morbidity, fever, nasal discharge, 
erosions of the alimentary canal and diarrhea. They could 
experimentally transmit the disease to calves, and noted 
that certain clinical signs of illness resembled those 
caused by rinderpest. They termed this disease syndrome 
"bovine virus diarrhea'' (BVD) of cattle (46). 
Later, Walker and Olafson (63) in 1947 proved con-
elusively by both cross-immunity and neutralization tests 
that there was no antigenic relationship between rinderpest 
virus and the causative agent of the new disease syndrome. 
Ramsey and Chivers (50) in 1953 and Ramsey (49) in 1954 
reported the occurrence in Iowa and surrounding states of a 
newly recognized syndrome in cattle. They named the syndrome 
:mucosal disease" (MD) of cattle because it mainly affected 
the mucosal surfaces. Their description of the disease differs 
from that reported for BVD by more pronounced lesions in the 
alimentary tract, greater differences in morbidity and 
mortality rates, and the epizootiology of the syndrome. 
However, they were not able to reproduce the typical disease. 
In 1954, B~ker et al. (3) isolated two strains of virus 
from field cases resembling those described by Olaf son 
et al. ( 45). They designated these isolates New York 1 (NY 1) 
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and Maine 2 (M 2). When calves were inoculated intravenously 
or intranasally with infective blood or splenic emulsion, a 
diphasic temperature response accompanied by leukopenia and 
general malaise occurred. Diarrhea occured in about half of 
the inoculated calves, but oral lesions were observed only 
in an occasional animal. By cross-protection tests in calves, 
they found both viruses to be antigenically related and con-
cluded that these isolates were similar to Olafson's isolate 
even though the original material was not available for 
comparison. They were unable to detect neutralizing anti-
bodies by injecting calves with mixtures of splenic emulsion 
and serum from inoculated calves. Likewise, they found no 
fixation of complement when using the infective splenic 
preparations as antigen in the complement-fixation test. The 
infective agents would not grow in embryonating eggs or guinea 
pigs, but could be transferred in rabbits. After 75 serial 
passages in rabbits, the NY 1 virus became modified and only 
produced a slight decrease in leukocytes and mild temperature 
elevation when inoculated into calves. The modified virus 
immunized the calves against fully virulent virus challenge. 
In 1956, Pritchard et al. (48) described the widespread 
occurrence in Indiana of a syndrome which closely resembled 
BVD as reported by Olafson (45). They isolated a virus from 
a field case and were able to reproduce the syndrome experi-
mentally in calves. They named the agent Indiana 143 and 
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found immunological differences when compared to the reference 
NY 1 virus by quantitative cross-protection tests in calves. 
Lee and Gillespie (41) in 1957 were able to grow and 
maintain the NY 1 strain isolated by Baker et al. (3) for 20 
consecutive passages in bovine embryonic skin-muscle tissues 
prepared in roller tubes by the plasma-clot method. The virus 
was maintained for an additional 15 transfers in bovine 
embryonic kidney cell cultures. The concentration of virus 
in fluids from these tissue-cultured cells were virulent for 
calves at dilutions of 10-5 to 10-7. However, the NY 1 strain 
did not produce any evidence of cytopathic effect (CPE) in the 
tissue culture systems. 
Underdahl et al. (62) in 1959 were the first to isolate 
and propagate cytopathogenic viruses from field cases of MD. 
They isolated and cultivated in bovine embryonic kidney cells 
two cytopathogenic viruses from separate herds which they 
designated M-833 and ISC-1. Cytopathic changes in the tissue 
cultures were observed 7 to 10 days following inoculation, with 
small vacuoles forming within the cells and increasing in size 
until the cell layer was completely destroyed by 10 to 14 days. 
The viruses were inactivated by temperatures above 50 C for 
15 minutes and would pass an 03 Selas filter. Both viruses 
stimulated formation of neutralizing antibodies in sheep, 
but they failed to determine if their viruses would produce 
the experimental disease in calve~. Subsequent studies by 
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Gillespie et al. (24) in 1961 have shown that Underdahl's 
isolates are immunologically related to the reference NY 1 
virus. 
Noice and Schipper (44) in 1959 also isolated a cyto-
pathogenic virus in bovine kidney cell cultures from field 
cases diagnosed as MD. Intravenous inoculation of two calves 
produced a mild syndrome characterized by a single temperature 
elevation 6 to 10 days postinoculation (PI). The calves 
developed neutralizing antibodies to the virus in approxi-
mately 15 to 25 days. This virus has been referred t o as 
the North Dakota agent. As far as can be determined, the 
North Dakota virus is similar or identical to infectious 
bovine rhinotracheitis as reported by Tyler (60). 
In 1959 Gillespie and Baker (22) demonstrated by 
reciprocal immunity tests in calves that NY 1 virus and the 
Indiana 46 virus were immunologically related and produced 
similar syndromes in experimental calves. They propagated 
both strains in tissue cultures but observed no evidences of 
CPE. 
The isolation of a cytopathogenic virus by Gillespie 
et al. (23) in 1960 was one of the first major advances in 
the study of this disease syndrome. The virus was isolated 
from splenic tissue from a calf which had succumbed to a 
syndrome similar to BVD. The agent was designated Oregon C24V. 
After several passages in tissue cultures, CPE appeared in 2 
)• 
._, 
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or 3 days but was much more pronounced in 6 to 8 days. 
Affected cells became rounded and gradually detached from 
the glass surface, with complete detachment by the 12th to 
15th day. Stained cells showed homogeneity of the cyto-
plasmic vacuoles of varying size were commonly seen in 
infected cultures. Reciprocal cross-immunity tests in 
calves showed that the agent was immunologically related 
to NY 1 strain. Serum neutralization tests us ing tissue-
cultured Oregon C24V virus indicated not only a relationship 
with NY 1 but also with the Indiana 46 strain of virus. 
Since this time numerous cytopathogenic and non-
cytopathogenic BVD-MD viruses have been isolated and there 
is serological evidence of the disease throughout the world • 
Robson et al. (53) in 1960 studied the correlation 
between a neutralization test and immunity to BVD in 59 
experimentally infected calves. All calves were serologically 
negative at the time of the first inoculation, and all 
developed "typical signs of BVD. '' The calves were sero -
logically positive 2 to 4 weeks following the first inocula-
tion. Following challenge with virulent virus, none of the 
calves showed signs of illness. They concluded that the 
neutralization test for immunity was at least 95% accurate 
in the determination of the immune status of the animal . 
Even though they did not indicate, it is assumed the 
neutralization tests utilized tne Oregon C24V virus. 
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In 1964 Coggins (9) studied the neutralization test 
for BVD using Oregon C24V tissue-cultured virus. He found 
that from 30 to 300 TCID50 units of virus would give con-
sistent results and yet permit maximum sensitivity. In 
the neutralization test, an increase or decrease of 1 log 
unit of virus would result in an inverse change of 0.44 
log unit in the serum titer. He concluded that the neutra-
lization test was accurate within a 3-fold dilution if 
procedures were followed which controlled variables. 
Kniazeff and Pritchard (39) in 1960, used the plaque 
assay procedure to conduct neutralization tests on various 
BVD-MD antiserums against Oregon C24V virus. Antiserums 
used in this study were obtained from experimental animals 
exposed to known viral isolates. Fourteen antiserums 
against NY 1 strain of BVD were obtained from Florida, 
Indiana and New York, and an additional antiserum from 
an unidentified isolate was obtained from Nebraska. A 
total of 45 calf antiserums to MD agents were obtained 
from Indiana, Iowa, North Dakota and England. All of the 
preinoculation serums were found to have no detectable 
neutralizing antibodies when tested against Oregon C24V 
virus. They found an antigenic relationship between 
Oregon C24V virus and all of the anti-BVD and anti-MD 
serums tested. They concluded that the BVD-MD agent are 
members of an antigenically related group. The Oregon C24V 
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v irus was also utilized in the neutralization test a gainst 
serums obtained from cases of blue tongue , hog cholera, 
infectious bovine rhinotracheitis, bovine infectious 
ulcerative stomatitis, winter dysentery, malignant catarrhal 
fever, sporadic bovine encephalitis and bovine mycotic 
stomatitis. Even though these diseases have some similarity 
in their pathogenesis to the BVD-MD syndrome, no antigenic 
relationship was found by neutralization . 
Kniazeff et al. (38) , in 1961, reported that Oregon 
C24V virus was also neutralized by antiserums against BVD-MD 
viruses from Scotland and West Germany . They therefore 
concluded that BVD-MD agents occurring in various parts of 
the world are antigenically related. 
In 1961, Gillespie et al. (24) compared different 
strains of BVD-MD viruses by neutralization tests us ing 
antiserum against NY 1 virus. The viruses tested were 
Oregon C24V, a Nebraska BVD strain, a Nebraska MD strain, 
and three strains of BVD isolated in New York and designated 
as C55F, C60F and C80K. All of the viruses showed an anti-
genic relationship when compared by the neutralization test. 
They suggested that serological tests should be used before 
new and different disease entities are postulated on t he 
basis of clinical and pathological findings . 
Darbyshire (14), in 1962 , investigated the agar double 
diffusion technique as a me t hod of diagnosis for MD . A 
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total of 1323 tissues of various types were tested against 
immune MD serwn from 223 clinically affected cattle. Of 
these, tissues from 85 of the animals reacted with the 
immune serwn and 14 additional animals gave a doubtful 
reaction. The tissues from 20 healthy cattle did not 
show any lines of precipitation. He concluded that the 
agar double diffusion technique would be useful in the 
diagnosis of MD. 
Gutekunst and Malmquist (30), in 1963, separated a 
soluble antigen from infective virus particles by ultra-
centrifugation of infective tissue culture fluids. They 
showed that by concentrating the soluble antigen, a single 
line of precipitation would occur when tested in the agar 
double diffusion plates against immune serwns. The 
infective virus "pellet," however, failed to show a 
precipitin line. 
In 1964 , Gutekunst and Malmquist (29 ) reported a 
complement-fixation test for BVD-MD using soluble antigen 
prepared from infective tissue culture fluids. They were 
able to detect complement-fixing antibodies in experimentally 
infected animals, and demonstrated that the soluble 
antigen alone was antigenic in calves. 
Gratzek (28) , in 1962 , reported on a virus interference 
test which he used to detect noncytopathogenic BVD viruses 
in tissue cultures. In this system, tissue culture cells 
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infected with either NY 1 or Indiana 46 viruses were 
temporarily resistant to superinfection with vesicular 
stomatitis virus. 
In 1962, Gillespie et al. (25) reported a plaque 
inhibition assay method for detecting noncytopathogenic 
BVD viruses in tissue cultures. They found that cell 
cultures became resistant to 50 plaque-forming units of 
cytopathogenic C60F virus if noncytopathogenic strains of 
BVD viruses had been inoculated at least 3 days earlier. 
This cellular resistance was neutralized by BVD anti bodies. 
They suggested that this cellular resistance was explained 
by the principle of interference. 
Gutekunst and Malmquist (29) using a modification 
of the interference test described by Gillespie et al. (25 ) 
found that tissue cultures infected with noncytopathogenic 
strains of BVD viruses would show almost 100% interference 
when the cultures were challenged with 103 TCID50 of 
cytopathogenic NADL-MD virus. They were able to do neutrali-
zation tests with the noncytopathogenic viruses by the use 
of this interference principle. 
In 1963 Inaba et al. (36) described the use of the END 
method to detect noncytopathogenic strains of BVD. They were 
able to titrate noncytopathogenic viruses in bovine testicular 
cells by the ''exaltation" of CPE by newcastle disease virus as 
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compared to its effect in non-infected cultures. They also 
described a neutralization test using this technique. 
Fernelius (21) in 1964 was able to detect and titrate 
noncytopathogenic BVD viruses by the use of immuno-
fluorescence. He found that fluorescein-conjugated serum 
globulins against either a cytopathogenic or noncytopatho-
genie BVD-MD virus would stain infected cells of various 
noncytopathogenic BVD-MD viruses. Titration of noncytopatho-
genic viruses by immunofluorescence correlated with the 
results obtained by the interference technique described by 
Gutekunst and Malmquist (29). 
In 1962 Malmquist* observed that animals which succumb 
to MD failed to develop either neutralizing or complement-
fixing antibodies. He demonstrated a viremia in clinical 
cases for a period of 4 months prior to the animals' death. 
In each case, no antibodies against the virus were found, 
whereas other "healthy" animals in the herd developed 
significant levels of antibodies. He suggested that the 
inability of the clinical cases of MD to develop antibodies 
resembles the "immune tolerance or paralysis" phenomenon. 
Dinter et al. (18) in 1962 and Borgen (5) in 1963 
reporting on virological and serological studies of herds 
· *Malmquist, W. A., National Animal Disease Laboratory, 
Ames, Iowa. Observations on immune tolerance associated 
with the bovine viral diarrhea-mucosal disease syndrome . 
Private communication. 1962. 
13 
with evidence of MD, found no antibodies present in animals 
from which they isolated MD viruses . Other animals in the 
herd had no clinical signs of the disease but had high levels 
of neutralizing antibodies. Thomson and Savan (59) in 1963 
also observed in several cases that animals which became 
diseased and died were serologically negative. They 
suggested that the animals may have been incapable of an 
antibody response. They observed clinical signs in one case 
for over 2 months and the animal was still serologically 
negative immediately prior to death, at which time it still 
yielded virulent virus. 
The first evidence of a possible relationship between 
the causative agents of BVD-MD and hog cholera (RC) was 
reported by Darbyshire (15, 16) in 1960 and 1962. Using 
tissues from infected animals as antigens, he observed a 
line of identity in agar double diffusion plates when the 
antigens were tested against either RC or BVD-MD immune 
serums. In absorption experiments, he found that the RC 
antigen removed the antibodies from anti-hog cholera serum 
as well as the BVD antibodies in the bovine serum . Likewise, 
the MD antigen removed the precipitating antibodies from 
both types of antiserums . Normal tissues did not remove 
the precipitating activity of either antiserum and further-
more, the antigens were not affe cted by normal serums . 
Neither antiserums nor tissue autigens from infected animals 
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with canine distemper, canine hepatitis, myxomatosis, 
rabbit fibroma, swine pox, vaccinia, rinderpest, teschen 
and foot -and-mouth diseases showed any serological relation-
ship with BVD-MD or HC in the agar double diffusion plates. 
Bechenhauer et al. (4) in 1961 reported that pigs 
inoculated with Oregon C24V BVD virus were resistant to 
challeng~ with virulent HC virus 14, 24 and 37 days later . 
They found that two other isolates, Nebraska BVD and 
Nebraska MD, d i d not protect against subsequent challenge 
with virulent HC virus. Serial passage of Oregon C24V virus 
every 7 days in pigs did not cause it to increase in virulence, 
but the pigs were susceptible to HC after 2 to 3 passages. 
They 11 hyperimmunized" 2 pigs with Oregon C24V virus and found 
that large doses of the antiserum would protect pigs against 
challenge with virulent HC virus. They concluded that the 
immunity produced in pigs by the BVD virus was related to 
antibody formation rather than some type of blocking 
mechanism. 
In 1962 Sheffy et al. (56) found that SPF pigs inoculated 
wit h NY 1 or Oregon C24V BVD viruses would withstand challenge 
with virulent HC strain A virus. No signs of illness were 
noted following inoculation of BVD viruses and the pigs 
developed a low level of neutralizing antibodies against 
BVD virus, but no neutralizing antibodies against HC virus . 
Seven days after challenge with HC virus, high levels of 
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neutralizing antibodies were present against both BVD and 
HC viruses. After challenge with HC virus, the control 
pigs developed signs of illness and died in 8 to 15 days, 
whereas the pigs initially given BVD viruses showed a 
lesser elevation of temperature for 1 to 2 days and returned 
to normal. Likewise, a similar pattern was observed when 
calves were inoculated with HC virus and subsequently 
challenged with BVD virus. Serums which contained BVD 
antibodies did not neutralize HC virus and, in reciprocal 
·tests, serums that contained HC antibodies would not 
neutralize BVD viruses. They concluded that since BVD and 
HC viruses fail to cross-neutralize, the mechanism of pro-
tection appears to be related to an accelerated secondary 
response induced by prior exposure to a heterotypic virus . 
Kumagai et al. (40) in 1962 investigated the antigenic 
relationship between BVD and HC viruses by cross-neutraliza-
tion tests. They found the two viruses were antigenically 
different when convalescent serwns were used in the neutrali-
zation tests. However, they detected a slight cross -neutrali-
zation when hyperimmune serums were used in the test. They 
concluded that the two viruses share common "minor" antigens 
and the secondary response reported by Sheffy et al . (56) 
might be partly, if not entirely, due to the booster effect 
of these minor antigens common to both viruses. 
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In 1963 Gutekunst and Malmquist (30) separated a 
soluble antigen and infective virus particles from tissue 
culture fluids of NADL-MD and C24V viruses. They found 
that the soluble antigen of the BVD viruses would form a 
single line of identity in the agar double diffusion plates 
when reacted with anti-hog cholera and anti-BVD serums. 
However, infective virus particles failed to form precipitin 
lines with either type of antiserum. No neutralizing 
antibodies were found in the anti-HC serums when tested 
against the BVD viruses except in a commercially prepared 
serum. They suggested the relationship between BVD and HC 
viruses was due to the sharing of a common soluble antigen. 
Gutekunst and Malmquist (29 ) in 1964 demonstrated that 
the soluble antigen of BVD viruses could be used to assay 
complement-fixing antibody levels in anti-HC serums. Normal 
swine serums failed to fix complement when tested with the 
BVD soluble antigen. 
Mengeling et al. (43) in 1963 demonstrated the antigenic 
relationship between BVD-MD and HC viruses by immunofluoresc-
ence. By using fluorescein-conjugated serum globulins 
against either BVD or HC viruses, they were able to stain 
infected tissue cultures of either BVD or HC viruses. They 
found the staining to be specific and no fluorescence was 
observed when normal bovine or swine serum was used. 
.~ 
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In 1963 Dinter (17) reported HC and BVD-MD viruses to 
share similar physical and chemical properties . They were 
both approximately 50 mµ in size , ribonucleic acid (RNA) 
type, sensitive to ether and chloroform, moderately 
sensitive to trypsin and were not stabilized in cationic 
solutions. In reciprocal neutralizat ion tests he found 
some cross-neutralization if the antiserums were "very high" 
in titer, however, some would show no neutralization towar.d 
the heterologous virus. 
Coggins and Seo (10) in 1963 using rabbit antiserums 
against HC and BVD viruses, found no cross-neutralization . 
Inoculation of either virus followed by challenge with the 
other produced a secondary response to both . They suggested 
this to be additional proof of "heterotypic" relationship. 
In 1962 Gratzek (28 ) repor ted the adsorption rate of 
Oregon C24V virus in calf testicular cells to proceed 
rapidly and is essentially complete in 10 minutes . He 
noted a tendency towards acce lerated adsorption at 37 C 
over 26 C but suggested these difference s were within the 
confidence limits of the plaque assay method . A multicyclic 
growth curve of this virus in embryonic bovine kidney cells 
revealed maximal titers to occur from 3 to 7 days PI. Using 
calf testicular cells, he could detect cell-associated virus 
as early as 8 to 10 hours PI and found infective virus in 
the extracellular fluid approxima~ely 4 hours later . He 
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suggested that the testicular cells were more susceptible to 
this virus than were the kidney cells. 
Gillespie et al. (26) in 1963 obtained maximwn viral 
infectivity of C24V or c60F virus in extracellular fluids 
72 to 96 hours PI, with a marked decline in the titer 
following subsequent incubation. They found the virus in 
the fluid phase to exceed that of the cell-associated phase 
by at least one log during the growth of these viruses. In 
contrast, Coggins (9) reported the growth and release of 
C24V virus in tissue culture to be very gradual and reaching 
a maximwn titer only after 6 days 1 incubation . 
In 1949 Andrewes and Horstmann (2) were the first to 
observe that different viruses varied in their sensitivity 
to ethyl ether. Since this time, sensitivity to ether has 
been one of the major criteria used in the classification 
of viruses. Several workers have studied the susceptibility 
of BVD-MD viruses to ether. Hermodsson and Dinter (32) in 
1962 and Gillespie et al. (26) in 1963 reported C24V virus 
to be sensitive to 2<Y/:i ether when incubated at 4 C for 18 
hours. However, Taylor et al. (58) in 1963 reported C24V 
virus to be stable in the presence of ether. 
In 1961 Feldman and Wang (20) found that viruses which 
were sensitive to ether were also sensitive to the action of 
5~ chloroform when incubated at room temperature for 10 
minutes. They suggest that chloroform is more efficient 
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than ether because of its greater polarity as a lipid 
solvent, and offers the advantage of being readily separable 
by sedimentation. Hermodss on and Dinte r ( 32 ) have reported 
that C24V BVD virus is inactivated by chloroform. 
The type of nucleic acid of viruses has been investi -
gated by the use of inhibitors of deoxyribonucleic a cid (DNA) 
synthesis. In 1960 Salzman (54 ) found the growth of vaccinia 
i n tissue culture to be inhibited by the addition of 5-fluoro -
deoxyuridine (FUDR), whereas poliovirus was resistant . 
Herrmann (33) in 1961 reported that the addition of 5-iodo-
deoxyuridine (IUDR) or 5-bromo-deoxyuridine (BUDR) would 
inhibit the plaque formation of vaccinia and herpes simplex 
viruses, but had no effect on the RNA-containing viruses , 
West Nile and newcastle disease . Hermodsson and Dinter (32) 
and Ditchfield and Doane (19 ) found C24V BVD virus to multiply 
in tissue cul ture in the pre s ence of IUDR or BUDR. They 
concluded that the BVD-MD viruse s were RNA in type . 
Since the development of t he collodion membrane filters 
by Elford in 1929 , many workers have used various types of 
filters to estimate the size of virus particles. Hermodsson 
and Di nter (32 ) using mill ipore filters found C24V virus to 
readily pass the 100 mµ fil te r and r educed amounts of 
infective virus passed the 50 mµ fil ter . Taylor et al . (58 ) 
reported C24V virus would pass mill ipore filters or graded 
asbe stos filter pads having a po_.rosity of 100 mµ. However , 
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they were unable to detect any infective virus in the 
filtrate when the 50 mµ filters were used. 
Hermodsson and Dinter (32) using the electron micro-
scope observed spherical particles with a diameter of 
approximately 40 mµ from ultra-thin sections of concentrated 
C24V virus pellet. However, they thought the concentration 
of infective virus in the pellet was too low to permit an 
identification of the spherical particles as BVD viruses. 
Ditchfield and Doane (19) observed particles in electron 
micrographs of ultra-thin sections of tissue culture cells 
infected with C24V or MAC-A BVD viruses. The particles were 
approximately 150 to 250 mµ in size with periodic projections 
of 10 mµ. The internal component was in a form of a helix 
and had a diameter of 18 mµ. On this basis, they suggested 
that the BVD viruses belong to the myxovirus group. 
In 1962 Wallis and Melnick (64) described a new 
property for enteroviruses . They found that high concentra-
tions of cations would stabilize enteroviruses whereas they 
would enhance the thermal inactivation of certain viruses 
in the other major groups . They suggested that this 
characteristic is a key criterion in the differentiation 
of enteroviruses from others with similar properties. 
Dinter (17) in 1963 found that the thermal inactivation of 
C24V BVD was enhanced in molar solutions of Ca++ or Mg++ 
as compared to the control. Ditchfield and Doane (19 ) 
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repor ted C24V to be completely i nactivated in both the molar 
Ca++ s o lution and the control when incubated for one hour at 
50 c. 
A number of investigat ors have reported the results of 
thermal inactivation tests of BVD viruses under a variety 
of temperatures, times of exposure and other conditions not 
s t ated. Gratzek (28) found the titer of infective C24V BVD 
virus would decrease approximately one log in 24 hours when 
held a t either 37 C or 27 C. Thermal inactivation of the 
virus at 58 C resulted in a two-component curve which 
indicated the possibility of heat resistant var iants. He 
found a small amount of infective virus remains f ollowing 
1 hour's incubation. Taylor et al . (58 ) reported C24V virus 
to be completely inactivated by 96 hours when incubated a t 
37 C. They found the virus to survive at 56 C for only 20 
to 35 minutes. Coggins (9 ) reported no apprec iable loss in 
titer when C24V virus was held at 25 C for 24 hours . 
In 1958 Cheng (8) found t hat trypsin , chymotrypsin or 
papain would inactivate both the hemagglut inin and infectivity 
of t he group B arboviruses, whereas they had no appreciable 
effect on t he group A a rboviruses. He suggested this 
characteristic would aid i n t he differentiation of t he 
group A and B arboviruses . Dinter (17) found C24V BVD 
virus to be moderately sensitive to the enzymatic action 
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of trypsin, and thought this virus to resemble the group B 
ar boviruses in this characteristic. 
In 1956 Peterson and Sober (47) and Sober et al. (57 ) 
first described the preparation of DEAE- and ECTEOLA-
ce llulose ion exchangers and their use in column chroma-
tography of proteins. Hoyer et al. (35) were the first 
to use DEAE- and ECTEOLA - cellulose anion exchangers for 
column chromatography and purification of animal viruses. 
Since this time, numerous workers have used chromatographic 
separation techniques to purify viral preparations and in 
the separation of viral components. 
In 1951 Brakke (7) described a new separation 
technique, density gradient centrifugation. Using 
different densities of sucrose layered in a centrifuge 
tube, he was able to purify and separate potato yellow-
dwarf virus from other debris on the basis of their bouyancy 
in sucrose solutions during high speed centrifugation . 
Since that time, various modifications of this technique 
have been used to separate and purify viral components. 
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PART I. VIRUS CHARACTERIZATION 
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MATERIALS AND METHODS 
Since a variety of tissue culture med ia and buffe r 
solutions were utilized in this study, a description of 
each is included in the appendix. 
Tissue Culture System 
Primary bovine embr yonic kidney (BEK) cell cu ltures 
were used throughout this study . Cell cultures were pre-
pared by the general method of Youngner (65). Kidneys were 
collected aseptically f rom selected 6-9 months bovine fetuses 
and placed in a s terile container of Hanks ' balanced salt 
solution (HBSS ). The capsule was r emoved from the kidney, 
and the cortical region separated from the medullary r egion . 
The cortical tissue was minced until approximately 1 mm3 
pieces were obtained . The minced cortical tissue was washed 
3 times with cold GKN solution, with the washing flu ids 
being discarded. The tissues were placed in a sterile 
trypsinization flask* containing a sterile tef lon-covered 
magnetic stirring bar. Sterile trypsin solution (0. 25%) 
chilled to 4 c was added to the trypsinization flask and 
incubated at 4 C for 4 to 6 hours. Afte r incubation the 
supernatant fluid which contains toxic debris was discarded 
and fre sh cold trypsin was added . Trypsinization was 
*Bellco Glass Company, Vineland , N. J. 
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continued for an additional 18 hours at 4 C. Following 
trypsinization, fibrous tissue was separated from the 
trypsinized cells by filtration through sterile cheesecloth. 
The cells were sedimented by centrifugation at 1,000 x g 
in a refrigerated centrifuge and the supernatant fluid was 
discarded . The cells were then washed 3 times with cold 
GKN and diluted in HESS containing 10% specific pathogen-free 
( SPF ) calf s erum to give a final cell concentration of 
approximately 1 x 106 cells/ ml. The BEK cells were pro-
pagated i n sterile tissue culture tubes, 4 - oz prescription 
bottles or Blake tissue culture bottles depending on the 
requirements for the experiments . The ce l ls were plant ed 
in medium containing 89.5% HBSS, 0.5% lac talbumin hydrolysate , 
10. 0% SPF calf serum, and penicillin and streptomycin at a 
concentration of 100 units and 100 µg/ ml, respectively. 
After 3 days' incubation at 37 C, the medium was changed 
to 89.5% Earles' balanced salt solution (EBSS), 0 .5% 
lactalbumin hydrolysate, 10% SPF calf serum, and also 
containing antibiotics . 
After complete monolayers had fo rmed in approximately 
5 days, t he medium was r emoved and the cultures were washed 
3 times with warm phosphate buffered saline solution (PBS). 
Depending on the experiment, the cultures were washed with 
warm PBS following inoculation and adsorption period and 
Eagles ' basal medium (EBM) containing 2.0,% SPF calf serum 
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was added for maintenance. The cultures were incubated in 
stationary racks at 37 C and observed twice daily for the 
duration of the experiment. 
Viruses Used 
The bovine viral diarrhea (BVD) virus used for 
characterization in this study was isolated from a clinical 
case occurring in a group of yearling Holstein heifers at 
the National Animal Disease Laboratory, and was designated 
NADL-MD strain of BVD virus. The virus was isolated from 
the following tissues: oesophageal mucosa, abomassal mucosa, 
Peyer's patch, mesenteric lymph node, spleen, bone marrow, 
rectal and nasal swabs . Primary isolations were made in BEK 
cell cultures. Virus neutralization tests and typical 
cytopathic effect (CPE) demonstrated that all isolates 
were identical . 
The virus was purified by 3 terminal endpoint dilutions, 
and virus passaged 8 or 9 times in primary BEK cell cultures 
was used throughout the experiment unless otherwise stated. 
Since most research on BVD viruses has been with 
Oregon C24V strain, isolated by Gillespie et al . (23), this 
virus was used in certain experiments as a control and to 
compare it with the test NADL-MD virus. 
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Assay Procedures 
Infective virus 
Cytopathogenic viruses were titrated in BEK cell tube 
cultures . The infective fluids were separated from cellular 
debris by centrifugation for 30 minutes at 2,000 x g in a 
refrigerated centrifuge . Serial 10-fold dilutions of the 
clarified tissue culture fluids were prepared in cold HBSS . 
Two-tenths ml of each dilution was inoculated into 5 BEK 
tube cultures. The cultures were incubated in a stationary 
rack at 37 C and observed twice daily for evidence of 
cytopathic effect (CPE). 
Noncytopathogenic viruses were titrated using the 
principle of viral interference described by Gillespie 
et al . (25) and modified by Gutekunst and Malmquist (29). 
Serial 10-fold dilutions of noncytopathogenic viruses were 
prepared in cold HBSS, and 5 BEK cell tube cultures were 
inoculated with 0.2 ml of each dilution. The cultures were 
incubated in stationary racks at 37 C for at least 72 hours 
to allow time for the higher dilutions to completely infect 
the culture . Following 72 hours' incubation, the medium 
was aspirated and the cultures were washed twice with warm 
PBS . One ml of EBM containing approximately 103 TCrn
50 
of 
cytopathogenic NADL-MD virus was then added to each culture . 
The cultures were incubated at 37 C and observed twice 
daily for evidence of CPE. If the noncytopathogenic virus 
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had propagated in the cultures there was almost lOOJb 
interference with the challenge cytopathogenic virus. Like-
wise, typical CPE of the challenge virus could be observed 
if the noncytopathogenic virus was not present in the culture. 
Fifty percent infective virus endpoints were calculated by 
the method of Reed and Muench (51). 
Serum neutralization 
The beta method of constant virus-varying serum dilutions 
was the procedure of choice for neutralization tests in this 
study. Test serums were heat inactivated in a 56 C water bath 
for 30 minutes. Serial 2-fold dilutions of each serum were 
prepared in HESS , then an equivalent amount of HBSS containing 
a pproximately 100 TCID
50 
per 0.1 ml of cytopathogenic virus 
was added to the serum dilutions. The mixtures were incubated 
at 37 C for 30 minutes, and 0.2 ml of each dilution was 
inoculated into each of 5 BEK cell tube cultures. The 
cult ures were incubated at 37 C and observed twice daily 
for e vidence of CPE. 
For neutralization tests involving noncytopathogenic 
viruses, the principle of interference as described pre-
viously was employed. Serial 2-fold dilutions of test serums 
were mi xed with equal amounts of HBSS containing approxi-
mately 100 Tcrn
50 
per 0.1 ml of noncytopathogenic virus . 
The mixtures were incubated at 37 C for 30 minutes, and 
0.2 ml of each dilution was inoculated into each of 5 BEK 
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cell tube cultures. After 96 hours' incubation at 37 C, 
the fluids were removed and the cultures washed twice with 
warm PBS. The medium in each tube was replaced with 1 ml 
3 EBM containing approximately 10 TCID
50 
cytopathogenic 
NADL-MD virus. The presence of unneutralized noncytopatho-
genic virus could then be detected by its interference with 
the cytopathogenic challenge virus. Fifty percent neutrali-
zation endpoints were calculated by the method of Reed and 
Muench (51 ). 
Complement fixation 
The complement source for the complement fixation (CF) 
test was prepared from pooled guinea pig serum by the pro-
cedure of Kabat and Mayer (37) . Blood was collected in 
individual sterile containers from approximately 50 guinea 
pigs and allowed to clot for 1 to 2 hours at room temperature . 
Any natural hemolytic antibodies were removed by absorbing 
twice with sheep erythrocytes . One-hundred ml of ice-cold 
guinea pig serum was mixed with 3 ml of packed sheep 
erythrocytes which had been washed 4-5 times in isotonic 
saline. The mixture was kept at 0 C for ten minutes , then 
centrifuged at 2,000 x g for 10 minutes at 0 C and the serum 
removed. The absorbed guinea pig serum was distributed into 
chilled ampules and promptly frozen at -60 C. 
Hemolysin was prepared by inoculation of rabbits wi th 
boiled sheep erythrocyte stromata as described by Kabat and 
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Mayer (37). One liter of sheep blood was collected in 250 ml 
of 3 .8% sodiwn citrate with continuous mixing. The blood was 
fil t ered through sterile cheesecloth to remove clumps, and the 
erythrocytes were sedimented by centrifugation at 4 C. The 
erythrocytes were then washed in two volumes of isotonic 
saline. Erythrocytes were "laked'' by slowly adding the 
erythrocytes, with constant vigorous mixing, to 10 liters 
of ice-cold acidified distilled water (4 ml glacial acetic 
acid to 10 liters distilled water). The mixture was stirred 
for approximately 10 minutes and allowed to stand at 4 C over-
night to permit the stromata to settle. The supernatant fluid 
was discarded and the stromata were washed 4-6 times with cold 
0.001 M acetate buffer, pH 5. After each washing, the stro-
mata were sedimented by centrifugation at 2,000 x g at 4 C. 
Following the final sedimentation the stromata were suspended 
in an equal volume of cold 0.15 M NaCl. After washing three 
times in 0.15 M NaCl, to remove the acetate, the stromata 
were suspended in 0.15 M NaCl to a total volwne of 300-400 ml. 
The stromata were heated for 1 hour in a 100 C water bath . 
The mixture was allowed to cool, then stirred by a magnetic 
stirring apparatus until a smoothly dispersed suspension was 
obtained . Rabbits were immunized with this suspension by 
intravenous inoculations according to the following sequence: 
One injection of 0.1 ml, five injections of 1 ml, and five 
injections of 2 ml, each. The series of 11 injections covered 
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a period of about 2 weeks, with not more than 2 consecutive 
days between any two injections. The rabbits were bled 4 to 
5 days following the last inoculation. The serum collected 
was inactivated at 56 C for 30 minutes and stored at -20 C. 
The sheep erythrocytes used in the CF test were obtained 
by collecting the blood in an equal volume of sterile, 
modified Alsever's solution. The sheep blood was stored at 
4 C and allowed to age for at least 1 week prior to use. 
After this stabilization period, a volume of blood sufficient 
for a day's work was withdrawn aseptically and centrifuged. 
The plasma and buffy coat were carefully aspirated and the 
sedimented cells were washed 3 times with 10 volumes of 
veronal-buffered saline containing Ca++ and Mg+ +. Following 
the final washing, the erythrocyte s we re suspended in 
veronal-buffered saline to a final concentration of 'Cfo . 
The CF technique was essentially the same as described 
by Schmidt and Lenne tte (55) and modified by Gutekunst and 
Malmquist (29 ) . The spec i fic soluble antigen used in this 
study was prepared as previously de scribed by Gutekunst and 
Malmquist (30). The soluble antigen was prepared from tissue 
culture fluids of NADL-MD virus and clarified of cellular 
debris by centrifugati on for 30 mi nutes at 2,000 x g in a 
r efrigerated centrifuge. Clarified tissue culture fluids 
were centrifuged for 2 1/2 hours at 98 ,500 x g in a Spinco 
Mode l L preparat ory ultracentrif~ge. Followi ng centrifugation 
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the supernatant fluid was carefully decanted and concentrated 
approximately 100-fold by pressure dialysis at 4 C using 
cellulose casing under nitrogen pressure. Chloroform was 
added to the resulting concentrated soluble antigen to a 
final concentration of 5% to inactivate any remaining 
infective virus particles. This emulsion was gently mixed 
for 30 minutes a t room temperature and the excess chloroform 
was removed by centrifugation at 2,000 x g for 20 minutes in 
a refr i gerated centrifuge. The supernatant fluid was dialized 
against frequent changes of veronal-buffered saline at 4 C 
for 4 to 5 days then stored at -40 C. 
The dose of soluble antigen to be used in the CF test 
was determined by "block" titration, with several dilutions 
of antigen concurrently titrated against successive dilutions 
of bovine anti-NADL-MD serum. One unit of antigen was taken 
as the highest dilution which would give 50% lysis with the 
highest dilution of antiserum. Two units of antigen con-
tained in 0.2 ml were utilized in the test. The antigen was 
also tested for non-specific hemolytic or anticomplementary 
activity. Control antigen consisted of tissue culture fluids 
' 
from normal BEK cell culture and prepared in the same manner 
as described for the specific soluble antigen. 
The guinea pig complement was titrated in the presence 
of soluble antigen and 2 exact units in a volume of 0 . 2 ml 
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were used in the test. The incubation period for the 
titration was 1 hour at 37 C. 
The ability of normal bovine serum to enhance the 
fixation of complement to certain virus-antibody complexes 
has been noted by numerous workers . In this study, unheated 
SPF bovine serum was added to optimally diluted complement 
at a concentration of 5% as described by Boulanger et al. (6). 
At this concentration, the normal bovine serum had neither 
anticomplementary nor non-specific activity with the soluble 
antigen. 
Hemolysin was titrated using 2 units of complement in 
0 . 2 ml containing 5% SPF bovine serum and 0 . 25 ml of a 'Cf, 
sheep erythrocyte suspension . Two units of hemolysin in 
0 . 25 ml were used in the CF test . 
Sensitized erythrocytes were prepared by mixing equal 
volumes of a 2 . 0% suspension of washed sheep erythrocytes 
and a dilution of hemolysin containing 2 hemolytic uni ts 
in a volume of 0.25 ml. The mixture was allowed to stand 
at room temperature for 10 minutes to become optimally 
sensitized. 
All test serums were heat inactivated at 56 C for 30 
minutes prior to testing . Ser i al 2-fold d ilutions of each 
serum were prepared in cold ve ronal-buffered salin . Two-
t enths ml of each dilut ion was dispensed into test tubes 
placed in an ice bath . Two un i ts of compl ement in 0 . 2 ml 
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containing 5% normal bovine serum was then added, followed 
by 2 units of antigen in a volume of 0.2 ml. Antigen, 
control antigen, serum, complement and hemolytic controls 
were added to the system to determine the presence of any 
non-specific activity of the reagents or test serums. 
Fixation was allowed to proceed at 4 C for approximately 
18 hours . Following the fixation period, the tubes were 
warmed in a 37 C water bath for 10 minutes, then 0 .5 ml 
of sensitized erythrocytes was added to each tube , and 
secondary incubation at 37 C was continued for 20-30 minutes 
depending on the complement controls. The CF titer of the 
serums tested was expressed as the highest initial dilution 
of serum showing 50% lysis. 
Growth Cycle 
The growth cycle of NADL-MD virus was determined in 
primary BEK cell cultures. Thirty 4-oz prescription bottles 
containing monolayers of BEK cells were washed 3 times with 
warm PBS . Each culture was inoculated with 1 ml of NADL-MD 
virus (3 x 106 TC I D
5
ofml). After 1 hour of adsorption at 
37 C, excess fluids were removed and the cultures washed 
3 times with warm PBS. These fluids were pooled and 
titrated for unadsorbed virus. Fifteen ml of EBM contain-
ing 'Cf, SPF calf serum was added to each culture for 
maintenance, then further incubated. 
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Two cultures were removed from incubation at 3-hour 
intervals for the first 12 hours and at 6-hour intervals 
for the next 96 hours. The supernatant fluids were har-
vested and clarified of cellular debris by centrifugation 
at 2 ,000 x g in a refrigerated centrifuge. The fluids 
were stored at -80 C until assayed for extracellular virus. 
The cells which remained attached to the glass were 
washed twice with warm PBS and disrupted in 15 ml of HBSS 
by several cycles of freezing and thawing in an alcohol-dry 
ice bath. The cellular debris was sedimented by centrifuga-
tion at 2,500 x g for 1 hour in a refrigerated centrifuge 
and the resulting supernatant fluids titrated for cell 
associated virus. 
Ether and Chloroform Sensitivity 
The procedure for determining the ether sensitivity of 
the virus was essentially the same as described by Andrewes 
and Horstmann (2). Absolute diethyl ether* was added to 
infective tissue culture fluids to a final concentration 
of 20]6 and allowed to react for 18 hours at 4 C. Following 
the refrigeration period, the mixture was centrifuged at 
2,000 x g for 20 minutes and the other layer removed . 
Res idual ether was r emoved by vacuum. Oregon C24V virus 
*Mallinckrodt Chemical Works, St . Louis, Missouri 
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was also tested for ether sensitivity in the manner 
described above. Controls consisted of both viruses to 
which 2af, PBS replaced the ether in the procedure. Both 
the ether treated and control preparation were assayed 
for infective virus. 
Sensitivity of NADL-MD and C24V viruses to chloroform 
was determined by the method described by Feldman and 
Wang (20). Sufficient analytical reagent grade chloroform* 
was added to infective tissue culture fluids to make a 
final concentration of 5%. Following 10 minutes of con-
tinuous shaking at room temperature, the mixture was 
centrifuged at 500 x g for 5 minutes. The sedimented 
chloroform appeared at the bottom of the tube and the 
clear supernatant fluid was r emoved and titrated for 
infective virus. 
Nucleic Acid Type 
The type of nucleic acid possessed by NADL-MD virus 
was investigated by the procedure of Hermodsson and Dinter 
(32) which employed two inhibitors of deoxyribonucleic 
acid (DNA) synthesis, 5-iodo-deoxyuridine (IUDR)** and 
*Mallinckrodt Chemical Works, St . Louis, Missouri. 
**Nutritional Biochemicals Corporation, Cle veland, Ohio. 
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5-bromo-deoxyuridine (BUDR)*. A known DNA virus, vaccinia**, 
as well as a known ribonucleic acid (RNA) virus, para-
influenza 3***, served as controls. Each DNA inhibitor was 
aseptically added to EBM containing 2% SPF calf serum at a 
concentration of 50 µg per ml of medium. The medium was 
removed from 3 racks (64 tubes per rack) of BEK cultures 
and replaced with EBM containing IUDR in first rack, BUDR 
in the second rack, and no inhibitors in the remaining rack. 
Following 2 hours' incubation, 0.2 ml of each virus (approx-
imately 103 TCID5ofml) was inoculated into 15 BEK cultures 
of each of the 3 sets of media. The supernatant fluids of 
5 replicate tubes from each of the 3 viruses in the 3 
different media were pooled immediately after inoculation 
and assayed for virus content . The remaining cultures were 
incubated at 37 C and observed twice daily for evidence of 
CPE . Sampling procedures were repeated at 3 and 6 days PI 
in order to determine the effect of the inhibitory chemicals . 
Ultrafiltration 
Tissue culture virus suspensions of NADL-MD and C24V 
viruses were passed through Millipore filters/ of different 
*Nutritional Biochemicals Corporation, Cleveland, Ohio. 
**Smallpox vaccine, Lederle Laboratories . 
***Obtained from Shipping Fever Project, NADL, Ames, Iowa. 
/ Millipore Filter Corporati~n, Bedford, Massachusetts. 
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pore size to estimate the size of the infective virus 
particles . The following filters sizes were used in this 
experiment: 220 ± 0.2 mµ, 100 mµ ± 8 mµ, 50 mµ ± 3 mµ and 
10 mµ ± 2 mµ. The filters were used directly from the 
sterile packages to avoid possible damage by autoclaving . 
Nitrogen pressure was used to facilitate filtration when 
the smaller pore size filters were used. The original 
virus sample and the filtrates were assayed for infective 
virus. 
Cationic Stability 
Since thermal stabilization by the addition of high 
concentrations of cations is a property of the enteroviruses, 
an experiment was conducted to test the cationic stability 
of NADL-MD virus by the procedure of Wallis and Melnick (64) . 
Two molar solutions of MgC12 and of Cac12 
were prepared in 
d istilled water and sterilized by autoclaving. Two ml of 
tissue culture virus was added to equal volumes of each 
cation solution making a final 1 molar solution . Equal 
quantities of sterile water and tissue culture virus served 
as controls . 
Immediately after mixing a portion was removed for 
assay and the remaining was placed in a 50 C water bath 
and titrated for infective virus following 30 and 60 
minutes' incubation. 
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PH Stability at 56 C 
The sensitivity of NADL-MD virus to thermal inactivation 
at 56 C was determined in isotonic veronal-acetate buffer 
solutions at various pH values. This buffer system was 
chosen because of its' wide range of pH values and elimina-
tion of possible specific ion effects when using different 
buffer systems. Since precipitates formed in buffers stored 
at 4 C for periods of 24 hours or longer, it was necessary 
to prepare buffers fresh each day . Buffer solutions ranging 
from pH 3 to 9 were sterilized by filtration through a 220 mµ 
Millipore filter. The pH of freshly prepared buffers was 
stable throughout the thermal inactivation period of 56 C. 
NADL- MD virus for this experiment was prepared in BEK 
cultures contai ning EBM alone since serum proteins have 
buffering activity. To facilitate the adjust ment of the 
pH of the virus preparation, the infective tissue culture 
fluids were dial ized against frequent changes of 0 . 005 M 
phosphate buffered saline (pH 7 . 0 ) at 4 C for 3 days. The 
dialyzed virus was dispensed in 1 1/ 2 ml volumes into vials 
and stored at -80 C. 
Two volumes of isotonic veronal-acetate buffer (3 ml) 
were added to 10 vials of virus materia l for each pH value. 
A preincubation sample was immediately adjusted to pH 7 . 0 
by the addition of 3 ml of appropriate isotonic veronal-
a cetate buffer and titrated fo r virus content . The 
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remaining vials were placed in a 56 C water bath. Samples 
were removed from the water bath at 15 minute intervals and 
immediately placed in an ice bath. The pH of the same was 
adjusted to 7 by the addition of 3 ml of appropriate buffer 
and then the samples were titrated for infective virus. 
The thermal stability of NADL-MD virus at 56 C was 
determined in buffers at pH's of 3, 4, 5, 6, 7, 8 and 9 . 
The pH of the buffers were checked during thermal inactiva-
tion and found to vary not more than 
the original pH value. 
Trypsin Sensitivity 
0 . 2 pH units from 
The sensitivity of NADL-MD and Oregon C24V viruses to 
the enzymatic action of trypsin was determined by the pro-
cedure of Dinter (17). Three times crystallized trypsin* 
was dissolved in 0 . 02 M phosphate buffered saline, pH 7.8, 
at a concentration of 1.0 mg per ml. The trypsin solution 
was sterilized by passage through a 220 mµ Millipore filter. 
Infective tissue culture fluids were dialized against 
frequent changes of 0.02 M phosphate buffered saline, pH 7 .8, 
at 4 C for 3 days. Equal volumes of trypsin solution and 
virus preparation were mixed and additional samples of virus 
were mixed with equal volumes of the same buffer to serve 
as controls . Portions were removed for assay prior to 
*Nutritional Biochemicals Corporation, Cleveland, Ohio . 
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incubation and the remaining placed in a 37 C water bath for 
1 hour. Prior to assay, the trypsin activity in each sample 
was inhibited by the addition of 0 . 2% 5X crystallized soybean 
trypsin inhibitor* in 0 .02 M phosphate buffered saline, 
pH 7.0. The samples were placed in an ice bath and titrated 
for infective virus in BEK cultures. 
Hemagglutination Procedure 
To determine if NADL-MD virus material possessed pro-
perties of hemagglutination, a procedure was used according 
to the general method described by Cunningham (13). Three 
different preparations of viral antigens were used in the 
hemagglutination (HA) test: 1) infective tissue culture 
virus, 2 ) infective tissue culture fluids concentrated 
approximately 100 times by pressure dialysis followed by 
dialysis against frequent changes of PBS at 4 C, and 
3) concentrated soluble antigen as prepared for the CF 
technique. 
Erythrocytes from various species were used in the HA 
test. Blood was collected aseptically into an equal volume 
of Alsever 1 s solution from the following species: bovine, 
chicken, day-old chicken, guinea pig, rabbit, mouse, sheep, 
swine, hamster and human type o. 
*Nutritional Biochemical Corporation, Cleveland, Ohio . 
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The erythrocytes were washed 3 to 4 times in 10 volumes 
of PBS. Following the final washing, a 0.5% suspension of 
each species of erythrocytes was prepared in sterile PBS. 
Duplicate sets of serial 2-fold dilutions of each 
antigen preparation were made in PBS. An equal volume of 
each dilution was added to 0.25 ml of PBS followed by 0.25 
ml of erythrocyte suspension. One set was incubated at room 
temperature for 2 hours and the other was refrigerated at 
4 C for approximately 18 hours . Patterns of sedimented 
erythrocytes were observed for evidence of hemagglutination. 
Chromatographic Separation 
Chromatographic procedures have been useful in 
separating various components from crude virus preparations. 
In this experiment, an anion exchange cellulose column was 
utilized to separate NADL-MD viral antigens by increasing 
the molarity of NaCl in a buffer solution as described by 
Hoyer et al. (35). Ten grams of diethylaminoethyl (DEAE) -
cellulose (0. 91 meq/ g)* were washed in 250 ml of sterile 
water . The cellulose was allowed to settle at 4 C and the 
fine particles were aspirated with the supernatant fluids. 
The washing process was repeated 3 times. Following the 
last washing, the DEAE-cellulose was equilibrated with 
*Bio-Rad Laboratories, Richmond, California. 
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several changes of 0.01 M tris(hydroxymethyl)aminomethene-
HCL*, pH 7.4 at 4 C. A slurry of DEAE-cellulose in tris 
buffer was added to a 1 cm chromatographic column and care-
fully packed to a depth of 7.5 cm by the aid of nitrogen 
pressure. The column was further equilibrated by allowing 
approximately 250 ml of tris buffe r to pass through the 
column. 
NADL-MD virus material for chromatographic separation 
was prepared in BEK cultures in EBM medium without serum or 
phenol red indicator. The infective tissue culture fluids 
were concentrated at least 100 times by pressure dialysis 
at 4 C, then dialyzed against frequent changes of tris 
buffer for 3 days. 
The chromatographic procedure was conducted at 4 C. 
The previously equilibrated DEAE-cellulose column was loaded 
with 1 ml of concentrated virus material. The column was 
then eluted stepwise with 4 ml aliquots of tris buffer con-
taining increasing molarities of NaCl. The flow rate through 
the column was adjusted to approximately 20-30 drops per 
minute by the use of nitrogen pressure. Eluates were 
collected dropwise in 2 ml volumes. The infectivity of 
each sample was de termined by titration in BEK cultures. 
*Sigma Chemical Company, St. Louis, Missouri. 
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The complement-fixing activity of each sample was 
determined by the CF technique. 
Sucrose Density Gradient Centrifugation 
Sedimentation in a density gradient has been a very 
useful technique for separation and purification of viral 
components. The sucrose density gradient technique was 
used in this experiment for separation of NADL-MD virus 
components by a procedure described by Brakke (7). 
Analytical reagent grade sucrose* solutions were prepared 
in sterile distilled water at concentrations of 15, 30, 45 
and 50% respectively. Gradient columns were prepared by 
carefully layering 1 ml of each aqueous sucrose solution 
in a sterile centrifuge tube. The gradient tubes were 
allowed to equilibrate at 4 C for at least 24 hours. The 
viral material was prepared in the same manner as for the 
chromatographic separation procedure except the material 
was dialyzed against frequent changes of sterile saline at 
4 C for 2 days . After the gradient tubes had equilibrated, 
0 .5 ml of concentrated virus material was carefully overlaid 
on the sucrose gradient. An additional gradient column was 
overlaid with 0.5 ml of crystallized bovine albumin (10 mg 
protein nitrogen/ml )** to serve as a control. The gradients 
*Mallinckrodt Chemical Works, St. Louis, Missouri. 
**Armour and Company, Chicago, Illinois . 
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were centrifuged in a SW-39L swinging bucket rotor of the 
Spinco Model L ultracentrifuge for 18 hours at 35,000 rpm . 
Rapid acceleration with non-braking deceleration was used 
to minimize convection and stirback. 
Various techniques were investigated for collecting 
samples from the gradient tubes. The technique which gave 
clear-out separation of the samples with the least amount 
of mixing was used in this study. It consisted of individual 
0.5 ml pipettes held in a fixed vertical position and 
connected to a 2 ml syringe with non-collapsible tubing . 
Gradient tubes were held in a glass receptacle affixed to 
an adjustable stage for vertical positioning of the sample 
in reference to the fixed pipettes . Successive 0.5 ml 
aliquots were carefully collec ted from just below the 
meniscus by slowly elevating the gradient column . Each 
al iquot was assayed for infective virus in BEK cultures 
and for soluble antigen i n the CF t est . Protein nitrogen 
de termination of e ach sample containing bovi ne albumin was 
made by the b iuret me t hod (27). 
Relationship of NADL- MD Agent to other Bovine Viral Diarrhea 
Viruses 
The relationship of NADL -MD virus to other viruses of 
the BVD-MD complex was determined by neutralization tests. 
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The cytopathogenic viruses, NADL-MD and Oregon C24V (23)* 
were compared by the use of anti-NADL-MD serum prepared in 
an SPF calf. The following noncytopathogenic viruses were 
titrated and compared in the neutralization test by the 
principle of interference: NY 1 (3)*, Indiana 46 (48)*, 
Merrell (61)*, Sanders (52)* and CG-1220 (29). 
The soluble antigens of NADL-MD, Oregon C24V and 
CG-1220 viruses were compared in the CF test. Two CF units 
of each were used to titrate the complement-fixing antibody 
content in anti-NADL-MD and anti-CG-1220 serums prepared in 
SPF calves . 
Relationship of NADL-MD Agent to other Virus Groups 
Reciprocal cross-neutralization tests with other viruses 
and their antiserums were performed to determine possible 
relationship with NADL-MD virus. The following viruses and 
antiserums were tested; infectious bovine rhinotracheitis 
(IBR) virus and antiserum**, parainfluenza-3 and antiserum**, 
vesicular stomatitis***, vaccinia, anti-hog cholera 
*Obtained from Doctor D. E. Tyler, Iowa State University, 
Ames, Iowa. 
**Obtained from Shipping Fever Project, NADL, Ames, Iowa. 
***Obtained from Doctor L. 0. Mott, NADL, Ames, Iowa. 
' . 
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serum*, anti-transmissible gastrointerititis serum (TGE)*, 
anti-group B arborvirus serum**, and anti-Lymphocytic 
choriomeningitis (LCM) serum***· 
The antiserums listed above were also tested against 
the soluble antigen of NADL-MD in the CF test. Procom-
plementary activi ty of the anti-hog cholera and anti-TGE 
serums were removed by the procedure described by Cowan (12). 
One ml of each test serum was heat inactivated at 56 C for 
30 minutes . The serum was a llowed to cool at room tempera-
ture, the n 0.2 ml of a 1:80 dilution of formal i n was added 
to each test serum. The mixture was incubated for 45 
minutes at 37 C. Immediately after incubation, the serum 
was serial 2-fold diluted in cold veronal-buffered saline 
and used in the CF test. 
Animal Experimentation 
An SPF calf was inoculated with NADL-MD virus to 
s tudy and characterize the exper imental disease . 
Experimental animal 
A Holstein calf was procured by the animal quarant i ne 
sec tion at the National Animal Disease Laboratory under 
*Obtained from Doctor A. L. Mcclurkin, NADL, Ames, Iowa . 
**Obtai ned from Doctor T. H. Works , Chief, Viro logy 
Section, Communicable Disease Center, Atlanta, Georgia. 
***Diagnostic Reagent s Section, Communicable Di sease 
Center, Atlanta, Georgia . 
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conditions which approximated SPF production methods as 
described by Edward et al.* The calf was deprived of 
colostrum and held approximately 5 months in a unit com-
pletely separated from other animals. Subsequent neutral iza-
tion tests with preinoculation serum against the agent under 
study proved the complete absence of antibody to the NADL-MD 
virus. Daily observation and establishment of basal 
temperature and leukocyte counts were performed over a 
4-day period preceding artificial exposure. 
Inoculum and exposure 
NADL- MD virus was passed twice in BEK cultures then 5 
ml tissue culture fluid containing approximately 106 TCID
50 
were inoculated intravenous ly into the calf. Twelve weeks 
following the first inoculation, a s econd intravenous injec-
tion of 5 ml NADL-MD virus was given. 
Collection of data 
Beginning 24 hours PI and continuing daily for approxi-
mately 3 weeks , blood samples were obtained for total and 
differential leukocyte counts. Serums recovered from 
weekly bleedings were used for neutral ization and CF tests . 
Citrated blood was collected for buffy coat cultures each 
day f or 1 week and at weekly intervals thereafter, with the 
*Edward, A. G., Miles, G. D. and Calhoun, J. R., 
National Animal Disease Laboratory, Ames, Iowa. Production 
of colostrum deprived specific pathogen-free calves. Private 
communication. 1962. 
Iii 
I .! 
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exception of the 4th day PI when a pre-scapular l ymph node 
biopsy was performed . Swabs were used to collect material 
from intestinal contents and nasal secretions at the same 
time as the blood for the buffy coat cultures . Rectal 
temperatures and cl inical signs were recorded 3 times daily. 
Virus isolation technique 
Buffy coat cultures were prepared by a procedure 
similar t o that de scribed by Malmquist and Hay (42) for the 
propagation of swi ne l eukocytes . Approximately 25 ml of 
blood was collected aseptically from the experimental calf 
into 5 ml of a 10'% sodium citrate solution . Citrated blood 
samples were centrifuged at 2,000 x g for approximate ly 30 
minutes and the plasma aspirated . Recovered buffy coat cells 
were washed 2 to 4 times i n a Ca free sa lt solution (GKN ), 
care being taken to exclude as many erythrocytes as possible 
f rom each r e covery . Four washings were used when the 
presence of antibodies was anticipated . Buffy coat cells 
were planted with a growth medium containing 80% EBM and 
20% isologous serum . In most instances paired sets of 
cultur e s media were prepared, one incorporating preinocula-
tion s e rum and the other with serum collected at the same 
time as the buffy coat cells. After 5 to 7 days ' incubation 
a t 37 C the buffy coat cu ltures were reinoculated into BEK 
cultures . Rectal and nasal swabs were washed out in EBM 
which was clarified by centrifugation and inoculated into 
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BEK cultures. The pre-scapular lymph node biopsy material 
was minced with sterile scissors after which it was distri-
buted into tubes of growth medium and incubated as explant 
cultures. After the lymph node cells had formed monolayers, 
they were then subcultured into BEK cell cultures. The 
production of a CPE in the cultures similar to that pro-
duced by the original virus inoculum served as criterion 
of successful recovery of the virus. The isolates were 
further identified by virus neutralization tests. 
Serum neutralization and complement fixation 
Serums collected at weekly intervals from the experi-
mental calf were inactivated at 56 C for 30 minutes and 
serial 2-fold dilutions of each were prepared. The serums 
were tested against infective NADL-MD virus in the 
neutralization test and against the soluble antigen in 
the CF test. 
Necropsy 
The calf was necropsied 16 weeks following the first 
inoculation. Various tissues were aseptically collected 
for virus isolation and buffy coat and bone marrow cultures 
were also prepared. A thorough search for gross lesions 
was made and those observed were described. 
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RESULTS 
Growth Cycle 
Ninety-two percent of the virus in the inoculwn was 
adsorbed to the BEK cells during a 1 hour incubation at 
37 c . The first appreciable cell associated virus was 
detectable at 9 hours PI and reached a peak at 18 hours 
PI when the first evidence of CPE was observed. Over 99% 
of the total virus yield was released into the supernatant 
fluids by the time the cultures evidenced 50% CPE. The 
release of virus into the extracellular fluids appears 
to be by gradual release, rather than by "burst ," as 
occurs with bacteriophages . The complete cell layer was 
destroyed within 48 hours PI (Figure 1). 
Ether and Chloroform Sensitivi ty 
NADL-MD and Oregon C24V viruses were completely 
inactivated by treatment with 20% ether for 18 hours 
at 4 C, and no detectable infective virus remained in 
the fluids following the removal of ether (Table 1). 
Both viruses were sensitive to chloroform at a con-
centration of 5% when incubated at room temperature for 
10 minutes (Table 1). 
Figure 1. Growth cycle of NADL-MD virus in .bovine embryonic kidney cell cultures 
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Table 1. Ether and chloroform sensitivity of NADL-MD and 
Oregon C24V 
Virus 
NADL-MD 
Oregon C24V 
Ethera 
control treated 
5.8c 
5.5 
<1.0 
<1.0 
a20% ether for 18 hours at 4 C. 
Chlorof ormb 
control treated 
6.2 
5.8 
<1.0 
<1.0 
b5% chloroform for 10 minutes at room temperature. 
cTiters expressed as log10TCID5
ofml. 
Nucleic Acid Type 
Inhibitors of DNA synthesis, IUDR and BUDR, did not 
inhibit the replication of NADL-MD virus in BEK cultures 
at a concentration of 50 µg per ml of medium. However 
vaccinia, a DNA virus, was inhibited by both IUDR and 
BUDR. The RNA virus, parainfluenza-3, showed a normal 
replication in the presence of the 2 DNA inhibitors 
(Figure 2) . 
Ultrafiltration 
Both NADL- MD and Oregon C24V viruses readily passed 
through the 220 mµ and 100 mµ millipore filters. A small 
fraction of both viruses passed the 50 mµ filter, but no 
infective virus was present in the filtrate when the 10 mu 
filter was used (Table 2). 
Figure 2. Nucleic acid type determination of NADL-MD using DNA inhibitors, 
IUDR and BUDR, in BEK cell cultures 
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Table 2. Ultrafiltration studies of NADL-MD and Oregon C24V 
viruses 
NADL-MD Oregon C24V 
Filter size control filtrate control filtrate 
220 mµ 6.2a 5.8 5.5 4.8 
100 mµ 6.2 4.5 5.5 3.8 
50 mµ 6.2 1.2 5.5 1.2 
10 mµ 6.2 (1.0 5.5 <LO 
aTiter expressed as log10 TCID5
ofml. 
Cationic Stability 
The thermal inactivation of NADL-MD virus was enhanced 
when incubated at 50 C in the presence of 1 M solutions of 
either Ca++ or Mg++ as compared to inactivation of the virus 
in equal quantities of water (Table 3). Ca++ appeared to 
have a greater effect on the therma inactivation of the 
virus than the Mg+~. 
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Table 3. Cationic stability of NADL-MD virus to thermal in-
activation at 50 C in presence of 1 M Ca++ or Mg++ 
Incubation time (minutes) MgC12
a CaC1
2
b H20 
0 6.2c 6.o 6 . 2 
30 4.5 4.2 5 .8 
60 3.2 2.8 4.5 
aone molar solution at 50 c. 
bone molar solution at 50 c. 
cTiter expressed as loglO TCID5
dml. 
PH Stability at 56 C 
NADL-MD virus was relatively stable to thermal inactiva-
tion at 56 C in buff er solutions of pH 6 to 8, with a small 
amount of infective virus remaining after 2 hours' incubation. 
A two component inactivation curve at these pHs indicate 
possible heat resistant variants. The inactivation of the 
virus at 56 C was greatly enhanced at pH 5 or below 
(Figure 3). 
Trypsin Sensitivity 
Both NADL-MD and Oregon C24V viruses were moderately 
sensitive to the enzymatic action of trypsin . Ninety-nine 
percent or more of each virus was inactivated when incubated 
for 1 hour at 37 C i n the presence of trypsin (Table 4) . 
Figure 3. Thermal inactivation of NADL-MD virus at 56 C in buffer solutions 
at various pH values 
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Table 4. Sensitivity of NADL-MD and Oregon C24V viruse s to 
the enzymatic action of trypsin for 1 hour at 37 C 
Virus Control 
NADL-MD 
Oregon C24V 
Trypsin Treated 
2.5 
2.8 
8.lriter expressed as log 10 TCID5
ofml. 
Hemagglutination Test 
Difference 
2.7 
2.0 
No hemagg lutination was detectable when either of the 
3 antigens were tested in the HA test with the erythrocytes 
of various species and incubated at room temperature or at 
4 C for 18 hours (Table 5). 
Table 5 . Hemagglutination tests of NADL- MD viral antigens 
with various spec ies ' erythrocytes 
Erythrocytes 
Bovine 
Chicken 
Day-old chicken 
Guinea pig 
Rabbit 
Mouse 
Tissue culture 
virus 
25 c 4 c 
Concentrated 
virus 
25 c 4 c 
Soluble 
antigen 
25 c 4 c 
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· Table 5 (Continued) 
Erythrocytes 
Sheep 
Swine 
Hamster 
Human type O 
Tis sue culture 
virus 
25 c 4 c 
Concentrated 
virus 
25 c 4 c 
Chromatographic Separation 
Soluble 
ant igen 
25 c 4 c 
Separation of the soluble antigen from the infective 
virus particle was accomplished by elution from a DEAE-
ce llulose column with increasing molaritie s of NaCl. Most 
of the soluble antigen was eluted from the co lumn in the 
range of 0 . 1 and 0 . 2 M NaCl i n 0.01 M tris buffer, pH 7 .4. 
Elution of infect i ve vi rus required 0 . 5 M NaCl in tris 
buffer and a "virus trail" followed with the addit ion of 
highe r molarities of NaCl (Figure 4). The soluble antigen 
was assayable in t he CF test , however, the infective virus 
failed to fix complement. 
Sucrose Density Gradient Centrifugation 
Sedimentation in a sucrose density gradient yielded 
partly purified soluble antigen and infective virus particles. 
I nfective virus, as determi ned by titration in BEK cul tures, 
Figure 4. Chromatographic separation of NADL-MD viral components in DEAE-cellulose 
by increasing molarity of NaCl in 0.01 M tris buffer pH 7 .4 
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was located near the bottom of the gradient column in the 
higher densities of sucrose. The complement-fixing soluble 
antigen was located near the top of the gradient in the 
lower densities of sucrose (Figure 5). Sample number 9, 
taken from the bottom of the gradient tube, showed anti-
complementary activity in the CF test. However, after the 
sucrose was removed by dialysis, no anticomplementary 
activity remained. As in the chromatographic procedure, 
the samples containing the infective virus particles failed 
to fix complement. The bovine albumin was found in slightly 
lower densities of sucrose than the soluble antigen 
(Figure 5). 
Relationship of NADL-MD Agent to other Bovine Viral Diarrhea 
Viruses 
Neutralization tests using serial 2-fold dilutions of 
anti-NADL-MD serum against 100 Tcrn50 of Oregon C24V, NY 1, 
Indiana 46, Sa nders, Merrel and CG-1220 viruses showed an 
antigenic relationship, but to a lesser degree than the 
homologous NADL-MD virus. The cytopathogenic Oregon C24V 
virus showed a lower neutralization titer than any of the 
noncytopathogenic viruses when tested against anti-NADL-MD 
serum (Table 6). 
Soluble antigens prepared from NADL-MD, Oregon C24V 
and CG-1220 viruses and each standardized in the CF test 
I 
I 
! 
Figure 5. Sucrose density gradient centrifugation of 
NADL-MD virus components 
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yielded results within one dilution titers of each when 
tested against anti-NADL-MD and anti-CG-1220 serums 
(Table 7). 
Table 6. Neutralization tests using serial 2-fold dilutions 
of anti-NADL-MD serum against 100 TCID of dif-
ferent bovine viral diarrhea viruses 50 
Viruses 
Cytopathogenic 
NADL- MD 
Oregon C24V 
Noncytopathogenicb 
New York l 
Indiana 46 
Sander 
Merrell 
CG-1220 
Serum 
Preinoculation Post inoculation 
<4 
<4 
<4 
<4 
<4 
<4 
5,400 
128 
256 
180 
320 
512 
1,530 
~iters expressed as reciprocal of final serum dilution. 
brnterference test utilized to titrated and detect. 
Table 7. Comparison of the soluble antigen of NADL-MD, 
Oregon C24V and CG-1220 in the complement- fixation 
test with anti-NADL-MD and CG-1220 serums 
Anti-NADL-MD serum Anti-CG-1220 s erum 
Soluble Preinoc- Preinoc-
a ntigen ulation 4 week 6 week ulation 4 week 6 week 
NADL-MD <5 16oa 1280 <5 320 640 
Oregon C24V <5 80 1280 <5 320 640 
CG-1220 (5 160 1280 <5 160 640 
aTiters expresses as reciprocal of the initial dilution 
exhibiting 50% lysis . 
Relationship of NADL-MD agent to other Virus Groups 
No demonstrable neutralizing antibodies were detected 
when NADL-MD virus was tested against anti- IBR, anti-
parainfluenza-3 , anti-hog cholera, anti-TGE, anti-group B 
arbovirus and anti-LCM serums. Likewise no neutralizing 
antibodies were detectable when IBR, parainfluenza-3, 
vesicular stomatitis and vaccinia viruses were tested 
a gainst anti-NADL-MD serum. 
Anti-hog cholera serum had a complement-fixing titer 
of 320 when tested against the soluble antigen of NADL-MD 
virus, whereas no detectable complement fixation was found 
in the other antiserums listed above . 
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Animal Experimentation 
The SPF calf inoculated with NADL-MD virus showed a 
clinical response similar to that reported for other BVD-MD 
agents. 
Clinical observations 
An initial temperature rise of 2 . 5 degrees occurred in 
the experimental calf 24 hours following inoculation with 
NADL-MD virus. Following a brief remission, a definite rise 
occurred on the 6th and 7th days PI . The temperature slowly 
returned to normal in the subsequent 4 days with an additional 
temperature rise occurring 2 weeks PI. Thereafter the 
temperature remained relatively normal even after challenge 
with virulent NADL-MD virus 12 weeks following the initial 
exposure (Figure 6). 
With the initial temperature rise the calf was depressed 
and showed lack of appetite. A mild lacrimation and mucous 
nasal discharge were present. Four days PI the pre-scapular 
lymph nodes were enlarged approximately 3 times and a biopsy 
was performed at this time. On the 4th to 7th day PI, the 
calf exhibited lamititis and would stand with an arched back, 
moving only with difficulty. The calf became very weak and 
depressed with a complete loss of appetite. Excessive 
salivation and lacrimation with increased respiration were 
observed. The calf had a slight diarrhea on the 6th and 7th 
days with excessive amounts of mucous present in the discharge . 
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On the 8th to 10th days, erythemia of the mucous membranes 
of the buccal cavity was noted. The calf's muzzle had a 
"boiled appearance ." The calf was very dehydrated and had 
lost approximately 100 to 150 lbs . of weight. After 2 weeks 
PI, the calf began eating and drinking and rapidly returned 
to normal . No clinical signs were observed following 
challenge with virulent virus 12 weeks after the initial 
exposure. 
Hematologic observation 
The total leukocyte count f ell to approximately 40% of 
the preinoculation level 24 hours PI, then rose to about 
60% of the normal in 3 days . A marked leukopenia occurred 
on the 6th and 7th days when total leukocyte counts were 
approximately 7<::!% below the normal . The total leukocyte 
count slowly returned to normal in approximately 4 weeks, 
with the exception of a slight depression occurring on the 
15th and 16th days PI. No significant change i n t otal 
l eukocyte counts were observed when the calf was challenged 
with virulent NADL-MD vi rus. The depressions in total 
l e ukocyte counts closely correlated with the rises in 
temperature (Figure 6). 
Differential leukocyte counts indicated a drop in total 
lymphocyte s and neutrophils as compared to the normal . At 
the time of greatest total leukocyte depression, total 
lymphocyte s were approximately 41% below the normal and a 
Figure 6. Leukocyte and temperature res ponse in an SPF calf inoculated with 
NADL-MD virus 
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decrease of 49% was observed in the total neutrophil count. 
Other leukocyte numbers did not vary appreciably from pre-
inoculation counts . 
Antibody response 
Neutralizing antibodies were detectable in the serum 
2 weeks PI and rapidly increased to a peak titer at 6 weeks . 
Compl ement-fixing antibodies were dete cted prior to neutral-
izing antibodies and reached their highest levels a t 6 we eks 
PI , thereafter they remained relatively constant for the 
duration of the experiment. There was a rapid rise in 
neutralizing antibody levels following the second injection 
of virulent NADL-MD virus, with no apparent effect on the 
complement-fixing antibody level (Figure 7). 
Virus isolation 
The virus was recoverable for only 1 week PI when serum 
collected at time of buffy coat preparation was utilized in 
the growth medium, however, the virus was isolated during 3 
weeks PI when preinoculation serum was used in the medium 
(Table 8) . I t should be noted that the recovery of virus 
at 2 and 3 week PI occurred at a time when there was 
significant neutralizing and complement-fixing antibodies 
pre s ent (Figure 7). The virus was not recoverable at any 
time fol lowing the second injec tion of virulent virus . 
Figure 7. Antibody response and virus recovery from an SPF calf inoculated with 
NADL-MD virus 
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Culture of the biopsy material from the pre-scapular 
lymph nodes 4 days PI demonstrated the virus to be present 
at that time (Table 8 ). 
No virus was recover ed from daily rectal or nasal 
swabs (Table 8). 
Recovered viruses were considered to be identical to 
the original agent when typical CPE was observed in tissue 
cultures and confirmed by virus neutralization. 
Table 8 . Virus recovery from an SPF calf· exposed to NADL-MD 
virus 
Days Buffy Lymph Rectal Nasal 
Postinoculation coat node swab swab 
1 positive N.T. a negative negat ive 
2 II " 
,, II 
3 " " " " 
4 N.T. positive 
,, 
" 
5 positive N.T. " 
,, 
6 " II " II 
7 II " II " 
14 II b II " II 
aNot t ested. 
bpositive when preinoculation serum was used in the 
medium but negative with simultaneously collected 
serum. 
] 
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Table 8 (Continued) 
Days Buffy Lymph Rectal 
Postinoculation coat node swab 
21 "b " " 
28 negativec " " 
35 "c 
,, " 
cNegative when preinoculation or simultaneously 
collected serum was incorporated in the medium. 
Necropsy 
Nasal 
swab 
,, 
" 
" 
The calf was necropsied 16 weeks following the original 
exposure to NADL-MD virus. Six healed ulcers were present 
in the oral mucosa, occurring mainly on the dental pad and 
tongue. Numerous elongated areas of necrosis and erosion 
were present in the epithelial lining of the esophagus, being 
more prominent in the posterior region. Almost the entire 
epithelial surface of the abomasum was denuded and hyperemic. 
A marked catarrhal enteritis was observed in the small 
intestine, with the most severe lesions i n the duodenum 
and jejunum. The mucosa was hyperemic and edematous with 
excessive catarrhal exudate in the lumen. The Peyer's 
patches were edematous and enlarged approximately 2 times . 
The enlarged Peyer ' s patches were distinctly outlined by 
marked hyperemia with an occasional erosion on the mucosal 
surface. The remaining portion of the intestine appeared 
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to be normal except for a small amount of catarrhal exudate. 
The mesenteric lymph nodes were enlarged and edematous with 
a few petechial hemorrhages on the surface. The spleen was 
approximately 1/ 2 normal size and appeared to be largely 
devoid of lymphoic material. No other gorss lesions were 
observed. 
Bone marrow cultures prepared from the femur at time 
of necropsy yielded a virus which was identical to the 
original agent in CPE and by virus neutralization. No 
virus was recovered from the other tissues tested or by 
buffy coat cultural technique. 
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DISCUSSION 
The general characteristics of this new isolate most 
closely resembles the BVD-MD group of viruses. However, 
the CPE produced by the NADL-MD agent in cell cultures is 
more rapid and complete as compared to the most studied BVD 
virus, C24V. Likewise, the replication and release of this 
agent is more rapid than that of C24V. In examining the 
growth cycle of NADL-MD virus in BEK cell cultures, over 
99 .9% of the total virus yield is released into the super-
natant fluid by 24 hours PI when approximately 50% of the 
cells show evidences of CPE. In comparison, Gratzek (28) 
observed maximum titers of C24V in the supernatant fluids 
from 3 to 7 days PI and likewise Gillespie et al. (26) 
obtained maximum yield in 3 days but reported a marked 
decline in titer following subsequent incubation. However, 
Coggins (9) reported the multiplication of C24V virus as 
being very gradual and reaching maximum titer only after 
6 days' incubation. 
In this study, a substantial amount of the virus was 
found to be released into the extracellular fluid at the 
first evidences of CPE which occurred at 18 hours PI. The 
complete cell layer was destroyed at 48 hours PI . However 
one must remember that in comparing growth cycles of 
viruses, the initial multiplicity of infection of the 
culture will have a bearing on the rapidity of CPE and 
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the occurrence of maximum titer in the supernatant 
fluids. 
Some virus was detectable in early extracellular and 
cell-associated samples when theoretically not enough time 
had elapsed for viral replication. Apparently the 3 cycles 
of washings following the initial adsorption period does 
not remove all of the "free" virus and some remains with 
the cell layer. This "free" virus could represent some 
that was adsorbed and subsequently released into the super-
natant fluids of the samples collected at O, 3, 6 and 9 
hours' PI. The small amount of virus in the cell-associated 
phase at O, 3 and 6 hours' PI could represent adsorbed 
virus which was not washed off or possibly virus that had 
not degraded prior to the eclipse phase. For these reasons, 
an accurate determination of the first appearance of cell 
associated and extracellular virus could not be made. 
However, an appreciable amount of cell associated virus 
was present at 9 hours' PI and reached a maximum titer at 
18 hours' PI. An increase in detectable extracellular virus 
was noted at 12 hours PI with a rapid rise to near maximum 
virus yield at 24 hours' PI. Using bovine testicular cells, 
Gratzek (28) was able to detect cell associated C24V virus 
at 8 hours' PI and extracellular virus as early as 12 hours' 
PI . I n experiments conducted by Gillespie et al . (26) with 
C24V virus, the cell associated virus curve followed a 
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similar pattern as the extracellular virus curve, but 
failed to reach as high titers . 
It would appear that bovine viral diarrhea viruses 
contain lipids which are essential for infectivity . The 
sensitivity of these viruses to treatment with ether or 
chloroform in this study compares with those reported by 
Hermodsson and Dinter (32) and confirmed by Gillespie 
et al. (26). However, Taylor et al. (58) reported C24V 
virus as being stable in 20% ether at 4 C for 24 hours. 
Even though the infective virus particles of NADL-MD are 
sensitive to chloroform no decrease in complement~fixing 
activity of the soluble antigen is apparent following 
inactivation of the infective virus particles. Chloroform 
treatment appears to be a more suitable procedure for 
establishing the sensitivity of viruses to lipid solvents 
because it requires smaller quantities, shorter incubation 
period and is more readily separable from the virus contain-
ing fluids as compared to ether treatment . 
It is apparent from this study that NADL-MD virus will 
multiply in tissue cultures containing inhibitors of DNA 
synthesis. However the control DNA virus, vaccinia , failed 
to replicate but parainfluenza 3, a RNA virus, showed nearly 
normal rate of growth. These results are similar to those 
found for C24V virus by Dinter (17) and Ditchfield and 
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Doane (19). It can be concluded that BVD-MD agents are RNA 
viruses. 
At the present time, the size and structure of BVD-MD 
viruses have not been adequately determined. In this study, 
both NADL-MD and C24V viruses readily passed the 100 mµ 
millipore filter and reduced amount passed the 50 mµ filter. 
These results are in accord with those reported by 
Hermodsson and Dinter (32) for C24V virus. However, 
Taylor et al. (58) reported C24V virus to pass through the 
100 mu filter but not the 50 mu filter. Using ultra-thin 
sections of C24V virus infected BEK cells, Hermodsson and 
Dinter (32) observed spherical particles approximately 40 mu 
in size by electron microscopy. However they could not be 
assured that these particles were the viruses. Recently, 
Ditchfield and Doane (19) observed particles with helical 
internal components approximately 150 to 250 mµ in size in 
ultra-thin sections of infected BEK cells. They suggest 
that the viruses of BVD are members of the myxovirus group 
and closely resemble the rinderpest-measles-distemper 
subgroup. Even though they had no serological evidences 
that the viruses they were working with were BVD agents, 
it would seem highly unlikely that the yield of infective 
particles which passed the 100 mµ and 50 mµ filters could 
be accounted for solely by infectious RNA. It appears 
' I 
84 
that further work will be necessary to elucidate the 
structure and size of these viruses. 
The thermal inactivation of NADL-MD and C24V viruses 
is enhanced in the presence of molar solutions of Ca++ or 
Mg++ when incubated for 1 hour at 50 C. The results of 
this study compares closely with those reported by Dinter (17) 
for C24V, however Ditchfield and Doane (19) found C24V to be 
completely inactivated in the presence of the cationic 
solution or in the control after incubation for 1 hour at 
50 c. 
Since high concentrations of cations stabilizes 
en teroviruses (64) but enhance thermal inactivation of the 
NADL-MD virus, this is additional evidence that the viruses 
of BVD-MD complex are not members of the enterovirus group . 
A considerable variation in the thermal inactivation 
rate of BVD viruses have been reported in the literature. 
Taylor et al. (58) found that C24V virus would not survive 
at 56 C for periods longer than 20 to 30 minutes. 
Ditchfield and Doane (19) reported it to be completely 
inactivated at 50 C for 1 hour . In contrast, Gratzek (28) 
observed a biomodial inactivation curve with a small amount 
of infective virus remaining after 1 hour ' s incubation at 
58 C. Preliminary studies with NADL-MD virus in tissue 
culture medium indicated the thermal inactivation pattern 
was similar to that reported by Gratzek for C24V virus, 
however it was noted that a considerable variation in the 
pH of the medium occurred during the incubation period. For 
this reason, the thermal inactivation of NADL-MD virus was 
determined in a buffer solution which did not vary in pH 
during the incubation period. In a buffer solution at 
pH 7.0, the virus was inactivated at a logarithmic rate 
during the first 45 minutes at 56 C and at a slower rate 
thereafter. A small amount of infective virus was detectable 
after 2 hours' incubation. This two-component curve 
indicates the possible presence of heat stable variants. 
The thermal inactivation is greatly enhanced in buffer 
solutions of pH 5.0 or below as compared to the virus in 
pH 7.0 buffer solution. The virus appears to be acid labile 
since it is unstable in buffer solution at pH 3.0. NADL-MD 
virus appears to be relatively stable to thermal inactiva-
tion when the pH of the medium is carefully controlled as 
compared to inactivation in tissue culture medium. 
The susceptibility of arboviruses to enzymatic action 
of trypsin is a useful criterion in the differentiation of 
members of the A and B groups. Cheng (8) has shown that 
the B group of arboviruses, unlike the A group, are sensitive 
to the enzymatic action of trypsin. Dinter (17) has 
reported C24V virus to be moderately sensitive to the 
effects of trypsin. The results of this study substantiates 
those of Dinter in regard to C24V virus and further supports 
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the similarity of NADL-MD agent to the BVD-MD group. In 
this characteristic, the BVD agents resemble the B group 
of arboviruses more closely than the A group. 
Hemagglutinin production was not detectable with 
NADL-MD virus by the technique employed in this study. 
However this does not exclude the possibilities of their 
presence since an exhaustive study was not done . Also 
Taylor et al. (58) found no hemadsorption of guinea pig 
erythrocytes to C24V virus infected tissue cultures. 
Both sedimentation in a sucrose density gradient and 
c hromatographic separation appear to be excellent procedures 
for the separation of soluble antigen from the infective 
virus partic l es . These techniques, alone or in combination 
with others, could be of use in future studies of BVD-MD 
viruses . With purified viral components, mono-specific 
antiserums could be prepared and utilized in stud ies to 
better characterize the viral components as well as to 
elucidate the role of each antigen in the production of 
antibody in animals . 
The results of this study are suggestive that the 
strains of BVD-MD viruses share closely related if not 
identical soluble complement-fixing antigens but vary 
somewhat in neutralizing antigens . In neutralization 
studies, homologous virus and antibody systems usually 
yield the highest neutralization titer, whereas 
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complement-fixation titers are similar regardless of 
whether the soluble antigen is prepared from homologous 
or heterologous BVD viruses. 
The relationship of BVD-MD viruses to hog cholera 
viruses appears to be limited to the sharing of soluble 
antigens. No antigenic relationship to other viruses was 
found in this study by the techniques employed. 
The NADL-MD virus was recovered during 3 weeks PI by 
culturing the buffy coat cells from an experimentally 
infected calf. Because of the presence of significant 
levels of antibodies 2 weeks PI, this recovery of the 
agent would indicate an intracellular site for the virus 
in the circulatory system. The isolation of the NADL-MD 
virus by culturing the marrow of the calf's femur at 
necropsy is of considerable interest. Even though the 
virus was not isolated from any other tissues, this would 
indicate the persistence of the virus even in the presence 
of high levels of circulating antibodies. However, the 
bone marrow is known to have decreased circulation which 
could possibly allow the virus to reside and multiply in 
the bone marrow cells without being neutralized. The virus 
could have been residual virus following the second injec-
tion 4 weeks prior to necropsy, however no virus was 
isolated by buffy coat cultures nor did the animal exhibit 
a temperature rise or leukopenia suggestive of viremia. 
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The high levels of antibodies maintained after clinical 
recovery, especially the complement-fixing antibodies, is 
added evidences of a "carrier" state. 
In recent years, the characterization and classification 
of animal viruses have been the concern of many prominent 
researchers in the field of virology. Cooper (11) and 
Andrewes et al. (1) have emphasized the importance of 
stable physical and chemical properties such as nucleci 
acid type, size, structure and ether sensitivity, as prime 
characteristics to be used for virus differentiations. 
Although the knowledge of the physical, chemical and 
serological properties of the viruses in the BVD-MD group 
is far from complete, an attempt to classify these agents 
according to the scheme of Cooper (11) and modified by 
Hamparian et al. (31) could be useful in a better under-
standing of these viruses. 
The NADL-MD strain of BVD-MD virus has RNA as its 
nucleic acid type which is the first criterion of the 
classification scheme. The agent is ether and chloroform 
sensitive and is acid labile, which are secondary and 
tertiary criteria. From the preceding characteristics, 
this virus should tentatively fall into the arbovirus 
or myxovirus groups. The arboviruses usually have a 
size of 30-50 mµ with a range of 20 to 100 mµ. Whereas, 
the myxoviruses are in the size range of 100-120 mµ but 
varying from 50 to 500 mµ in some filementous forms. It 
would appear that the size of the NADL-MD agent would 
approximate that of the arbovirus group rather than the 
myxoviruses. Using trypsin sensitivity as a characteristic 
to differentiate group A from group B arboviruses, NADL-MD 
virus reacts similar to the B group . 
Various workers have suggested different classifica-
tions for the BVD-MD group of viruses . Taylor et al . (58) 
s ugge sted that they belong to the adenovirus group, 
Dinter (17) thought they were similar to the arbovirus 
group, and Ditchfield and Doane (19) suggested they 
resembled myxoviruses . 
Since the BVD-MD viruses are sensitive to both ether 
and chloroform and are RNA viruses, these characteristics 
alone would exclude them from the adenovirus group. 
Both arboviruses and myxoviruses are of RNA type, ether 
labile and acid labile; the same properties exhibited by 
the BVD-MD agents. The viruses appear to be in the general 
size range of the arboviruses, however a great variation 
in size exists in both the arbovirus and myxovirus groups . 
The myxoviruses exhibit properties of hemagglutination, 
of hemadsorption and of virus elution. These properties 
have not been demonstrated for the NADL-MD virus. However 
hemagglutinins have not been detected from canine distemper 
and rinderpest, which are exceptions to the myxovirus group. 
I l 
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The characteristic cytopathology produced by myxoviruses 
consists mainly of cell lysis with the formation of giant 
cells or syncytia. In the author's experiences, no giant 
cells or syncytial formation have been observed with NADL-MD 
virus in tissue culture systems. 
It appears that the general characteristics of the 
BVD-MD agents resemble more closely those of the group B 
arboviruses than any other group. However, i t is not known 
if arthropods are associated with the BVD-MD syndrome whi ch 
is a distinctive characteristic of the arboviruses. Even 
though no relationship was demonstrated between NADL- MD 
virus and broad spectrum group B arbovirus antiserum 
and complement-fixing antigen, this would not exclude 
them from the arbovirus group . 
Our knowledge is insufficient at the present time to 
classify these viruses, however it appears they most closely 
resemble the group B arboviruses. Since BVD-MD and hog 
cholera viruses have similar physical and chemical pro-
perties and have a common soluble antigen, it would appear 
that they might eventually be placed in the same subgroup. 
However, the final classification of these viruses will 
require further intensive investigation. 
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SUMMARY AND CONCLUSIONS 
The physical, chemical and antigenic characteristics 
of a previously undescribed virus (NADL-MD) isolated from 
a clinical case of mucosal disease are reported. 
The growth cycle of NADL-MD virus was determined in 
BEK cell cultures. The first cell associated virus appeared 
9 hours PI and reached a peak at 18 hours. The first extra-
cellular virus was observed 12 hours' PI and over 9~ of 
the total virus yield was released into the extracellular 
fluids at 24 hours at a time when the cultures evidenced 
approximately 50% CPE. The cell sheet was completely 
destroyed in 48 hours. 
NADL-MD virus was sensitive to treatment with 20% 
e t her for 18 hours at 4 c. Likewise, it was inactivated 
after exposure to 5% chloroform for 10 minutes. 
The NADL-MD virus replicated in BEK cell cultures in 
the presence of IUDR and BUDR, inhibitors of DNA synt hesis. 
Vaccinia, a DNA virus, failed to multiply in the presence 
of these inhibitors whereas parainfluenza 3, an RNA virus, 
showed normal replication. 
Infective tissue culture fluids of NADL-MD virus 
readily passed the 220 mµ and 100 mµ millipore filters . 
A reduced amount of infective virus passed the 50 mµ 
filter, but no virus was detectable in the filtrate when 
a 10 mµ filter was used. 
I • 
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The thermal inactivation of the virus at 50 C was 
enhanced in the presence of molar Ca++ or Mg++ solutions, 
whereas high concentrations of cations stabilizes entero-
viruses to thermal inactivation. 
NADL-MD virus was relatively thermostable at 56 C in 
buffer solutions at pH 6.o to 8.0, with a small amount of 
infective virus remaining after 2 hours' incubation in a 
buffer solution at pH 7.0. A two component inactivation 
curve indicated possible heat stable varients . The 
inactivation of the virus was greatly enhanced in solutions 
of pH 5.0 or below. 
The virus was moderately sensitive to the enzymatic 
action of 1% trypsin when incubated for 1 hour at 37 C. 
No hemagglutination was detectable when various 
antigen preparations were tested with a variety of different 
species' erythrocytes and incubated at room temperature 
for 2 hours or at 4 C for 18 hours. 
The soluble antigen was readily separable from the 
infective virus particles by chromatographic procedure 
in a DEAE-cellulose column. Increasing molarities of 
NaCl in 0.01 M tris buffer solution were employed for 
elution. The soluble antigen was eluted with 0 . 1 and 
0.2 M NaCl solution, while the infective virus particles 
were eluted with 0. 5 M NaCl solution. A "virus trail" 
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occurred with the subsequent addition of solutions with 
increasing molarities of NaCl. 
Sedimentation in a sucrose density gradient likewise 
separated the soluble antigen from the infective virus 
particles. The infective virus particles were located 
near the bottom of the gradient in the higher densities 
of sucrose, whereas the soluble antigen was near the top 
in the lower densities. In the control tubes, the bovine 
albumin fraction was located near the top of the gradient, 
which corresponded closely to the position of the soluble 
antigen fraction. 
NADL-MD virus is antigenically related to other strains 
of BVD-MD viruses as determined by neutralization and 
complement-fixation tests. Homologous virus and antiserum 
systems have higher neutralizing titers as compared to 
heterologous systems. However, no differentiation could 
be made on this basis among the strains of cytopathogenic 
or noncytopathogenic viruses. NADL-MD, C24V and noncyto-
pathogenic CG-1220 viruses possess common soluble antigens 
as determined by the complement-fixation test using anti-
NADL-MD and anti-CG-1220 serums. 
No relationship was detectable with other viruses by 
neutralization or complement fixation except with hog 
cholera. The anti-hog cholera serum had a high level of 
complement-fixing antibodi es when tested against the 
I 
94 
soluble antigen of NADL-MD virus, whereas no neutralizing 
antibodies were detectable when tested against infective 
NADL-MD virus. 
A calf experimentally infected with NADL-MD virus 
responded with a typical diphasic temperature reaction 
which was accompanied by a marked depression in the number 
of circulating leukocytes. Complement-fixing antibodies 
appeared prior to the neutralizing antibodies , but both 
reached a peak 6 weeks PI. A rapid rise in neutralizing 
antibodies was observed following the second injection of 
NADL-MD virus with no apparent effect on the complement-
fixing antibody level. The virus was recovered by culturing 
the buffy coat cells during 3 weeks PI, at times when 
significant levels of both neutralizing and complement-
fixing antibodies were present. The virus was also 
recovered by culturing the calf's femor at necropsy, 16 
weeks after inoculation. 
The Oregon C24V bovine viral diarrhea virus, which was 
used as a control in some of the procedures, was found to 
have similar properties to the NADL-MD strain with the 
exception that the cytopathology produced in tissue cultures 
was not as pronounced or complete as that of NADL-MD virus. 
The general characteristics of the NADL-MD virus 
definitely places it in the BVD-MD group of viruses, and 
resembles most closely those of the group B arboviruses . 
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PART II . HERD STUDIES 
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MATERIALS AND METHODS 
After the occurrence of the clinical case of "mucosal 
disease" and subsequent isolation of the NADL-MD virus, a 
virologica l and serological study was conducted on the 
involved herd. 
Herd History 
The animal which exhibited clinical signs suggestive 
of MD and yielded the NADL-MD virus at necropsy in January 
1962, was in a group of 20 yearling Holstein heifers in 
the experimental herd at the National Animal Disease 
Laboratory. The experimental herd originated at the 
research station in Beltsville , Maryland, and had no 
additions in the past 70 years. The herd's history gave 
no indication of the presence of bovine viral diarrhea-
mucosal disease syndrome except varylng degree s of diarrhea 
were observed in t he calf crop for a 2 to 3 week period in 
early 1961 . The herd was mo ved to the new facilitie s at 
Ames , Iowa, in May 1961 . 
Examination of the remaining 19 heifers following 
the occurre nce of the clinical case revealed no clinical 
signs that were suggestive of the BVD-MD syndrome . 
Virus Isolation 
Individual buffy coat cultures were prepared from 
ci trated blood collected from the remaining 19 heifers . 
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Buffy coat cells were collected at intervals for 4 months 
following the clinical case of MD: approximately 2 months 
(3/ 20/ 62), 3 months (4/ 25/ 62) and 4 months (5/24/62). 
The cultures were prepared as described in part I with 
the exception that SPF calf serum was incorporated into 
the growth medium. After 5 to 7 days' incubation, the 
supernatant fluids from each culture was serially passed 
at least 3 times in BEK cell cultures before they were 
recorded as negative. Any virus recovered was identified 
by CPE and virus neutralization. 
Specimens of nasal secretions and intestinal contents 
were collected at the same time as the blood for buffy coat 
culture preparation. The specimens were handled in the 
same manner as described in part I. 
Serum Neutralization 
Individual serum samples which had been collected 
(5/23/ 61) at Beltsville prior to the herd's movement to 
Ames were tested for neutralizing antibodies against NADL-MD 
virus. Serum for neutralization tests was collected at 
2, 8, 12, 16 and 28 weeks following the occurrence of the 
clinical case. The 19 heifers were then used for experi-
mental purposes and no subsequent samples could be obtained. 
Each serum sample was heat inactivated at 56 C for 30 
minutes and serial 2-fold dilutions were prepared. 
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Neutralization tests were conducted as previously described 
against 100 TC ro
50 
of NADL-MD virus. 
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RESULTS 
Virus Isolation 
Buffy coat cultures prepared from the 19 apparently 
normal heifers 2 months following the clinical case yielded 
virus from 4 individual animals (4978, 4991, 5008 and 5048) . 
An additional isolation was made from heifer 4993 by buffy 
coat cultures at 3 months. No isolations were made 4 months 
following the clinical case (Table 9). All 5 isolates 
produced CPE characteristic of the original NADL-MD virus 
and appeared to be identical by virus neutralization. 
Viruses were isolated from fecal material from 12 of 
the 19 heifers. Ten isolations were made 2 months following 
the clinical case, 9 isolations at 3 months and 2 isolations 
at 4 months. Usually the same individual animal continued 
to shed virus in the feces as indicated by consecutive 
isolations. In general, agents isolated from rectal swabs 
produce a very rapid and similar type CPE, usually in 24 
ho urs . Two of the isolates, the only 2 tested, were not 
neutralized by anti - NADL-MD serum. No viruses were 
recoverable from the nasal secretions. 
Serum Neutralization 
Serum samples collected from the 20 animals prior to 
movement to the National Animal Disease Laboratory which 
was approximately 8 months before the occurrence of the 
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clinical case revealed the presence of significant amounts 
of neutralizing antibodies in all but 2 animals, 5030 and 
5045 . Animal 5030 deve loped clinical signs of mucosal 
disease and subsequently yielded the NADL-MD agent, and 
animal 5045 developed high levels of neutralizing antibody 
on the first serum collected following the occurrence of 
the clinical case in 5030. The individual neutralization 
titers of serum samples collected at various intervals are 
presented in Table 9. In general, the animals from which 
viruses were isolated from buffy coat cultures had 
relatively low levels of neutralizing antibodies present 
at the time of isolation, but subsequent samples indicated 
a substantial rise in the antibody levels . The mean 
neutralization titer of the 5 animals from which virus 
was isolated from buffy coat cultures is compared with 
the mean titer of the remaining 14 animals in figure 8 
to better illustrate the differences in antibody level. 
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Table 9. Serum neutralization titers of 20 animal pre -
ceding and following the occurrence of a clinical 
case of mucosal disease 
Animal 
Number 5/ 23/61 2/8/62 3/20/62a 4/25/62a 5/24/62a 8/22/62 
4965 160b 
4978 300 
4980 840 
4985 75 
4987 840 
4988 635 
4991 75 
4993 645 
4994 2650 
4998 ' 855 
5004 > 4096 
5008 30 
5017 •' 600 
5023 210 
5024 600 
104 
58 
840 
300 
1185 
400 
30 
160 
2650 
1190 
2650 
58 
840 
840 
840 
76 128 
30C 400 
600 256 
256 160 
1590 840 
855 635 
58C 840 
75 30C 
3600 3600 
3600 2650 
3600 > 4096 
30C 1024 
1600 3600 
1024 1600 
300 2650 
256 
2048 
645 
210 
>4096 
2650 
)4096 
2650 
>4096 
>4096 
>4096 
>4096 
>4096 
2650 
>4096 
645 
2650 
400 
1645 
>4096 
1210 
> 4096 
3600 
2650 
1200 
>4096 
>4096 
)4096 
3600 
4096 
aBuffy coat cultures were prepared only at these times. 
bTiters expressed as reciprocal of final serum dilution 
giving 5°'1 neutralization. 
cVirus identical to NADL-MD were isolated from buf fy 
coat cultures of these animals. 
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Table 9 (Continued) 
Animal 
Number 5/23/ 61 2/8/62 3/20/ 62a 4/25/62a 5/ 24/ 62a 8/ 22/ 62 
5030 < 4d 
5033 256 600 210 840 2650 3600 
5037 840 1024 600 1200 3600 > 4096 
5045 < 4 1024 640 1024 >4096 > 4096 
5048 160 25 16b 1024 >4096 >4096 
dAnimal which succumbed to mucosal disease and yielded 
NADL-MD virus . 
Figure 8 . Comparison of mean neutralization titers of animals from which NADL-MD 
virus was isolated with those of animals from which no virus was 
isolated 
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DISCUSSION 
It is apparent from this study that "normal" cattle 
may be "carriers" of the virus without showing clinical 
signs of the BVD-MD syndrome. Why one animal had such 
marked lesions and finally succumbed to the disease 
whereas other animals in the herd failed to show any 
clinical evidence of the syndrome is still unknown. 
It has been observed by various researchers (4, 18, 59) 
that animals that show clinical signs of ''mucosal disease 1' 
and subsequently succumb, fail to develop any neutralizing 
or complement-fixing antibodies and may have a viremia for 
a considerable period of time. Whereas others animals in 
the herd or in other herds may show only a mild clinical 
form of the disease and quite often appear normal. These 
animals usually develop high levels of neutralizing and 
complement-fixing antibodies. 
In this study, the virus that was isolated from the 
clinical case was also recovered from 5 "normal" cattle. 
However, the 5 "normal'' cattle had low levels of neutraliz-
ing antibodies present at the time of virus isolation, 
which increased in subsequent serum samples. 
The various immunological and clinical manifes t ations 
present in the BVD-MD complex appears to have similarity 
to the variety of responses which occur in LCM virus 
t 
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infections of mice. Mice can be infected in utero with 
LCM virus and carry the agent for many months. Inoculation 
of newborn mice may show only a slight affect whereas the 
same dose of virus given to adults approaches 100% 
mortality. The mice may become immune tolerant and have 
a persistent virus infection. The LCM virus can cause an 
extremely wide spectrum of clinical and pathological effects 
in the adults, ranging from inapparent, long-lasting infec-
tions through mild to severe illness with almost 100% 
mortality (34). The mechanism of immune tolerance in LCM 
virus infected mice might be similar to that which occurs 
in the BVD-MD syndrome. 
The viruses isolated from the fecal material in this 
study are probably enteric cytopathogenic bovine orphan 
viruses and no serological association with the disease 
agent could be determined. 
Further research is required to elucidate the mechanism 
of ''immunological tolerance or paralysis'' in animals which 
fail to develop specific antibodies and finally succumb to 
the BVD-MD syndrome, and why other animals may show only a 
mild syndrome and respond with antibody formation. 
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SUMMARY 
A. study was conducted on the herd from which the 
NADL-MD virus was recovered from a clinical case of MD. 
Viruses identical to the NADL-MD agent were isolated 
from 4 animals by culturing their buffy coat cells 2 months 
following the occurrence of the clinical case and from a 
5th animal at 3 months. No virus was recoverable from the 
19 animals by buffy coat cultures collected 4 months 
following the clinical case. 
Serum samples collected approximately 8 months prior to 
the occurrence of the clinical case revealed that all but 2 
of the 20 animals had significant levels of neutralizing 
antibodies present against NADL-MD agent. Of the 2 animals 
which had no detectable neutralizing antibodies, one 
developed clinical signs of mucosal disease and subsequently 
yielded the NADL-MD agent and the other had significant 
levels of antibodies when tested at the time of the 
occurrence of the clinical case. 
In general, the 5 animals from which the NADL-MD agent 
was isolated had very low levels of neutralizing antibodies 
prior to and at the time of virus recovery. However a 
significant rise in antibody levels occurred in subsequent 
serum samples. 
Viruses were recover ed from fecal material from 12 of 
the 19 animals. However, these viruses produced rapid CPE 
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and did not appear to be serologically related to the 
NADL-MD virus. In general, the animals from which viruses 
were isolated usually continued to shed virus in the 
feces as indicated by consecutive isolations from the 
same individual. 
No clinical signs suggestive of the BVD-MD syndrome 
were observed in the remaining 19 animals following the 
occurrence of the clinical case . 
1. 
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APPENDIX 
Hanks balanced salt solution (HBSS) 
NaCl 8 . oo grams per liter 
KCl 0.40 
,, II II 
MgS04 .7H20 0.20 
11 II II 
Na2HP04 .tt2o 0.06 
,, 
" II 
Glucose 1.00 " II II 
KH2Po4 
0.06 II 11 II 
CaC12 0.14 
II II II 
NaHco3 0.35 
II " II 
Earle balanced salt solution (EBSS) 
NaCl 6 . 80 grams per liter 
KCl .40 II 
,, II 
MgS04 .10 II II II 
NaH2Po4 . 125 " 
II II 
NaHco
3 
2 . 20 II II " • l 
Glucose 1.00 II II II 
CaC12 10.0 
II ,, II 
Lactalbumin hydrolysate 5 . 0 
,, II II 
Eagle Basal Medium (BSM) 
NaCl 6.8 grams per liter 
KCl .4 " II " 
NaH2Po4 .H20 
.14 II " " 
NaHco3 
2 . 2 II II " 
CaC12 0.2 
II II II 
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Eagle Basal Medium (EBM) (Continued) 
MgC12 .6H2o 0.17 grams per liter 
Glucose 1.0 II II 
,, 
Arginine . 021 
,, " II 
Cystine . 012 " II II 
Histidine .008 II " II 
Isoleucine .026 II II II 
Leucine . 026 II " " 
Lysine .026 II II II 
Methionine .008 II II " 
Phenylalanine .016 II II II 
Threonine .024 II II II 
Tryptophan .004 II II " 
Tyrosine .018 II II " 
Valine .024 II II II 
Glutamine .300 II II " 
Biotin 1.0 milligrams per liter 
Choline 1.0 II II II 
Folic Acid 1.0 II II II 
Nicotinamide 1.0 
,, " " 
Pantothenic Acid 1.0 " II II 
Pyridoxal 1.0 I I II II 
Thiamin 1.0 II II II 
Riboflavin 0.1 " 
,, II 
Phenol Red .04 " " II 
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GKN solution 
NaCl 8.0 grams per liter 
KCl o.4 
,, 
" " 
Glucose 1.0 
,, 
" " 
Trypsin solution 
Trypsin 2.0 grams per liter 
NaCl 8 .0 " II II ' . 
KCl o.4 II II 
II 
Glucose 1.0 II " II 
NaHco3 
0.84 •• " " 
Dulbecco phosphate-buffered saline {PBS) 
NaCl 8.0 grams per liter 
KCl 0.2 " II 
,, 
Na2HP04 
1.15 " " " 
KH
2
Po4 
0.2 " " " 
I 
CaC12 
0.1 " II " L 
MgC12 .6H20 
0.1 II II ll 
Modified Alsever's solution 
Glucose 20.5 grams per liter 
Sodium citrate 8.0 " " 
,, 
NaCl 4.2 
I I II II 
Adjust to pH 6.1 with citric acid. 
Veronal-buffered saline 
NaCl 8 . 5 grams per liter 
Na-5 , 5-diethyl barbiturate .0375 
II " II 
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veronal-buffered saline (Continued) 
5,5-diethyl barbituric acid .0575 grams per liter 
Add 0 . 5 ml of a stock solution containing 1 . 00 M MgC12 
and 0.30 M cac12 . 
Isotonic veronal-acetate buffer solution of Michaelis 
220 
Solution A 
Sodium acetate 
Na-5,5-diethyl 
barbiturate 
9.714 grams per 500 ml H2o 
14.714 II 11 11 II II 
Solution B 
All 
NaCl 8.5 grams per liter H2
o 
To obtain the pH solution desired, add 5 ml of 
solution A to 2 ml of solution B plus x ml (from 
table below) of 0 .1 Normal hydrochloric acid and 
18 minus x ml of H2o . 
x pH x pH 
0.0 9.64 6.5 6.12 
0.25 9 .16 7 . 0 5 . 32 
0.5 8.90 8.0 4.93 
0.75 8 . 68 9.0 4 .66 
1.0 8.55 10.0 4.33 
2 . 0 8 .18 11.0 4 . 13 
3.0 7.90 12.0 3.88 
4.00 7.66 13.0 3.62 
5.0 7.42 14.o 3.20 
5.5 7.25 15.00 2 .62 
6.0 6.99 16.o 
solutions were sterilized by passage through a 
mµ millipore filter. 
